Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  COVID-19

  Free Subscription


Articles published in Emerg Infect Dis

Retrieve available abstracts of 764 articles:
HTML format



Single Articles


    April 2024
  1. TANTIRAT P, Chantarawichian Y, Taweewigyakarn P, Kripattanapong S, et al
    Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021.
    Emerg Infect Dis. 2024;30:791-794.
    PubMed     Abstract available


  2. SOLER-IBORTE E, Rivera-Izquierdo M, Valero-Ubierna C
    Opportunistic Elizabethkingia miricola Infections in Intensive Care Unit, Spain.
    Emerg Infect Dis. 2024;30:834-837.
    PubMed     Abstract available


  3. SCHOLL M, Hohn C, Boucsein J, Moek F, et al
    Bus Riding as Amplification Mechanism for SARS-CoV-2 Transmission, Germany, 2021(1).
    Emerg Infect Dis. 2024;30:711-720.
    PubMed     Abstract available


  4. KENDIG NE, Bur S, Zaslavsky J
    Infection Prevention and Control in Correctional Settings.
    Emerg Infect Dis. 2024;30:S88-S93.
    PubMed     Abstract available


  5. PORTER LJ, Rapheal E, Huebsch R, Bastian T, et al
    Development and Evaluation of Surveillance System for Identifying Jail-Associated COVID-19 Cases in Minnesota, USA, 2022.
    Emerg Infect Dis. 2024;30:S28-S35.
    PubMed     Abstract available


  6. SABER LB, Kennedy SS, Yang Y, Moore KN, et al
    Correlation of SARS-CoV-2 in Wastewater and Individual Testing Results in a Jail, Atlanta, Georgia, USA.
    Emerg Infect Dis. 2024;30:S21-S27.
    PubMed     Abstract available


  7. HAGAN LM, Mosites E, Hughes-Baker L, Butler J, et al
    Carceral Health is Public Health.
    Emerg Infect Dis. 2024;30:S1-S4.
    PubMed    


  8. GURREY SO, Strick LB, Dov LK, Miller JS, et al
    Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
    Emerg Infect Dis. 2024;30:S17-S20.
    PubMed     Abstract available


  9. WADDELL C, Meehan A, Schoonveld M, Kaplan Z, et al
    Lessons Learned from COVID-19 Response in Correctional and Detention Facilities.
    Emerg Infect Dis. 2024;30:S5-S12.
    PubMed     Abstract available


  10. TUNSTALL AM, O'Brien SC, Monaghan DM, Burakoff A, et al
    Lessons Learned from Cross-Systems Approach to COVID-19 Pandemic Response in Juvenile Justice System, Colorado, USA.
    Emerg Infect Dis. 2024;30:S13-S16.
    PubMed     Abstract available


    March 2024
  11. PATERSON A, Cheyne A, Jones B, Schilling S, et al
    Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.
    Emerg Infect Dis. 2024;30:519-529.
    PubMed     Abstract available


  12. OGOTI BM, Riitho V, Wildemann J, Mutono N, et al
    Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023.
    Emerg Infect Dis. 2024;30:581-585.
    PubMed     Abstract available


  13. VU QM, Fitzpatrick AL, Cope JR, Bertolli J, et al
    Estimates of Incidence and Predictors of Fatiguing Illness after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2024;30:539-547.
    PubMed     Abstract available


  14. KECK JW, Adatorwovor R, Liversedge M, Mijotavich B, et al
    Wastewater Surveillance for Identifying SARS-CoV-2 Infections in Long-Term Care Facilities, Kentucky, USA, 2021-2022.
    Emerg Infect Dis. 2024;30:530-538.
    PubMed     Abstract available


  15. VON MOLLENDORF C, Ulziibayar M, Nguyen CD, Batsaikhan P, et al
    Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.
    Emerg Infect Dis. 2024;30:490-498.
    PubMed     Abstract available


    February 2024
  16. HODGES NF, Sparrer M, Sherman T, Mayer T, et al
    Integrating Veterinary Diagnostic Laboratories for Emergency Use Testing during Pandemics(1).
    Emerg Infect Dis. 2024;30:386-388.
    PubMed     Abstract available


  17. TAKEMURA T, Ankhanbaatar U, Settypalli TBK, Purevtseren D, et al
    SARS-CoV-2 Infection in Beaver Farm, Mongolia, 2021.
    Emerg Infect Dis. 2024;30:391-394.
    PubMed     Abstract available


  18. TORI ME, Chontos-Komorowski J, Stacy J, Lamson DM, et al
    Identification of Large Adenovirus Infection Outbreak at University by Multipathogen Testing, South Carolina, USA, 2022.
    Emerg Infect Dis. 2024;30:358-362.
    PubMed     Abstract available


  19. PORTER SM, Hartwig AE, Bielefeldt-Ohmann H, Marano JM, et al
    Experimental SARS-CoV-2 Infection of Elk and Mule Deer.
    Emerg Infect Dis. 2024;30:354-357.
    PubMed     Abstract available


  20. JUSTMAN J, Skalland T, Moore A, Amos CI, et al
    Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 2021(1).
    Emerg Infect Dis. 2024;30:245-254.
    PubMed     Abstract available


    January 2024
  21. LEE CY, Kuo HW, Liu YL, Chuang JH, et al
    Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  22. CHAVES TDSS, Perosa AH, Barbosa G, Ferreira DB, et al
    Betacoronavirus Infection Outbreak, Sao Paulo, Brazil, Fall 2023.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  23. EGBELOWO OF, Fox SJ, Gibson GC, Meyers LA, et al
    Model for Interpreting Discordant SARS-CoV-2 Diagnostic Test Results.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  24. EALES O, Plank MJ, Cowling BJ, Howden BP, et al
    Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  25. JEON S, Watson-Lewis L, Rainisch G, Chiu CC, et al
    Adapting COVID-19 Contact Tracing Protocols to Accommodate Resource Constraints, Philadelphia, Pennsylvania, USA, 2021.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  26. BAI Y, Du Z, Wang L, Lau EHY, et al
    Public Health Impact of Paxlovid as Treatment for COVID-19, United States.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  27. FOUNTAIN H, Migchelsen SJ, Charles H, Ram T, et al
    Rebound of Gonorrhea after Lifting of COVID-19 Preventive Measures, England.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  28. ZHAO S, Mok CKP, Tang YS, Chen C, et al
    Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.
    Emerg Infect Dis. 2024;30.
    PubMed     Abstract available


  29. RECTOR A, Bloemen M, Thijssen M, Pussig B, et al
    Respiratory Viruses in Wastewater Compared with Clinical Samples, Leuven, Belgium.
    Emerg Infect Dis. 2024;30:141-145.
    PubMed     Abstract available


  30. HAN E, Nabity SA, Dasgupta-Tsinikas S, Guevara RE, et al
    Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020.
    Emerg Infect Dis. 2024;30:136-140.
    PubMed     Abstract available


  31. OGATA T, Tanaka H
    SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan (Response).
    Emerg Infect Dis. 2024;30:207.
    PubMed    


  32. CHENG HY, Akhmetzhanov AR, Dushoff J
    SARS-CoV-2 Incubation Period during Omicron BA.5-Dominant Period, Japan.
    Emerg Infect Dis. 2024;30:206-207.
    PubMed    


    December 2023
  33. ZVIEDRITE N, Jahan F, Moreland S, Ahmed F, et al
    COVID-19-Related School Closures, United States, July 27, 2020-June 30, 2022.
    Emerg Infect Dis. 2023;30.
    PubMed     Abstract available


  34. ZANELLA MC, Pianca E, Catho G, Obama B, et al
    Increased Peripheral Venous Catheter Bloodstream Infections during COVID-19 Pandemic, Switzerland.
    Emerg Infect Dis. 2023;30.
    PubMed     Abstract available


  35. CHEUNG YYH, Lau EHY, Yin G, Lin Y, et al
    Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong.
    Emerg Infect Dis. 2023;30.
    PubMed     Abstract available


    November 2023
  36. ANDREIS TF, Cantarelli VV, da Silva MB, Helfer MS, et al
    Substantial Diversity in Cocirculating Omicron Lineages in Hospital Setting, Porto Alegre, Brazil.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  37. AHMED F, Nowalk MP, Zimmerman RK, Bear T, et al
    Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  38. PATEL S, Cumming F, Mayers C, Charlett A, et al
    Simulation Study of Surveillance Strategies for Faster Detection of Novel SARS-CoV-2 Variants.
    Emerg Infect Dis. 2023;29:2292-2297.
    PubMed     Abstract available


  39. TERAN RA, Gagner A, Gretsch S, Lauritsen J, et al
    SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022.
    Emerg Infect Dis. 2023;29:2257-2265.
    PubMed     Abstract available


  40. KIM DH, Kim DY, Kim KS, Han SH, et al
    Neurologic Effects of SARS-CoV-2 Transmitted among Dogs.
    Emerg Infect Dis. 2023;29:2275-2284.
    PubMed     Abstract available


  41. ARCARI G, Cecilia F, Oliva A, Polani R, et al
    Genotypic Evolution of Klebsiella pneumoniae Sequence Type 512 during Ceftazidime/Avibactam, Meropenem/Vaborbactam, and Cefiderocol Treatment, Italy.
    Emerg Infect Dis. 2023;29:2266-2274.
    PubMed     Abstract available


    October 2023
  42. QVESEL AG, Bennedbaek M, Larsen NB, Gunalan V, et al
    SARS-CoV-2 Variants BQ.1 and XBB.1.5 in Wastewater of Aircraft Flying from China to Denmark, 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  43. XIONG W, Cowling BJ, Tsang TK
    Influenza Resurgence after Relaxation of Public Health and Social Measures, Hong Kong, 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  44. IP YCA, Tan A, Ong J, Fernandez CJ, et al
    Anthropogenic Transmission of SARS-CoV-2 from Humans to Lions, Singapore, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  45. KURIBAYASHI ST, Kasamatsu A, Ikenoue C, Fukusumi M, et al
    SARS-CoV-2 Infection in Wrestlers after International Tournaments, April 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  46. HYAMS C, Challen R, Hettle D, Amin-Chowdhury Z, et al
    Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006?2022.
    Emerg Infect Dis. 2023;29:1953-64.
    PubMed     Abstract available


    September 2023
  47. MWANGA MJ, Lambisia AW, Morobe JM, Murunga N, et al
    New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  48. HARRISON RE, Hamada A, Haswell N, Groves A, et al
    Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  49. LAMPROS A, Talla C, Diarra M, Tall B, et al
    Shifting Patterns of Influenza Circulation during the COVID-19 Pandemic, Senegal.
    Emerg Infect Dis. 2023;29:1808-1817.
    PubMed     Abstract available


  50. BELLIZZI S, Letchford N, Adib K, Probert WJM, et al
    Participatory Mathematical Modeling Approach for Policymaking during the First Year of the COVID-19 Crisis, Jordan.
    Emerg Infect Dis. 2023;29:1738-1746.
    PubMed     Abstract available


    August 2023
  51. NABITY SA, Marks SM, Goswami ND, Smith SR, et al
    Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  52. MNDALA L, Chapuma C, Riches J, Gadama L, et al
    Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  53. CHAN YLE, Irvine MA, Prystajecky N, Sbihi H, et al
    Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  54. DU Z, Wang Y, Bai Y, Wang L, et al
    Estimate of COVID-19 Deaths, China, December 2022-February 2023.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  55. ANDRONESCU LR, Richard SA, Laing ED, Pisanic N, et al
    Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  56. MOONAN PK, Smith JP, Borah BF, Vohra D, et al
    Home-Based Testing and COVID-19 Isolation Recommendations, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  57. FALENDER RA, Mitchell PG, Guzman-Cottrill JA, Cieslak PR, et al
    Pediatric SARS-CoV-2 Seroprevalence, Oregon, USA, November 1, 2020-June 30, 2022.
    Emerg Infect Dis. 2023;29:1672-1675.
    PubMed     Abstract available


  58. HECHT G, Dale AP, Ruberto I, Adame G, et al
    Detection of Hantavirus during the COVID-19 Pandemic, Arizona, USA, 2020.
    Emerg Infect Dis. 2023;29:1663-1667.
    PubMed     Abstract available


  59. TOOMRE D, Kandula S, Shaman J
    Longitudinal Association of COVID-19 Hospitalization and Death with Online Search for Loss of Smell or Taste.
    Emerg Infect Dis. 2023;29:1711-1713.
    PubMed     Abstract available


  60. YOO BK, Iwamoto R, Chung U, Sasaki T, et al
    Economic Evaluation of Wastewater Surveillance Combined with Clinical COVID-19 Screening Tests, Japan.
    Emerg Infect Dis. 2023;29:1608-1617.
    PubMed     Abstract available


  61. MANGIONI D, Chatenoud L, Colombo J, Palomba E, et al
    Multidrug-Resistant Bacterial Colonization and Infections in Large Retrospective Cohort of Mechanically Ventilated COVID-19 Patients(1).
    Emerg Infect Dis. 2023;29:1598-1607.
    PubMed     Abstract available


  62. MCMANUS O, Christiansen LE, Nauta M, Krogsgaard LW, et al
    Predicting COVID-19 Incidence Using Wastewater Surveillance Data, Denmark, October 2021-June 2022.
    Emerg Infect Dis. 2023;29:1589-1597.
    PubMed     Abstract available


    July 2023
  63. NEWELL K, Fischer M, Massey S, Orell L, et al
    Temporally Associated Invasive Pneumococcal Disease and SARS-CoV-2 Infection, Alaska, USA, 2020-2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  64. KINOSHITA R, Arashiro T, Kitamura N, Arai S, et al
    Infection-Induced SARS-CoV-2 Seroprevalence among Blood Donors, Japan, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  65. ATHERSTONE CJ, Guagliardo SAJ, Hawksworth A, O'Laughlin K, et al
    COVID-19 Epidemiology during Delta Variant Dominance Period in 45 High-Income Countries, 2020-2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  66. TSANG TK, Huang X, Fong MW, Wang C, et al
    Effects of School-Based Preventive Measures on COVID-19 Incidence, Hong Kong, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  67. KUSAMA T, Takeuchi K, Tamada Y, Kiuchi S, et al
    Compliance Trajectory and Patterns of COVID-19 Preventive Measures, Japan, 2020-2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  68. EILERS B, Adelbai-Fraser MD, Collado JR, Van Dyke M, et al
    Patient Characteristics During Early Transmission of SARS-CoV-2, Palau, January 13-February 24, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  69. GOLD JAW, Adjei S, Gundlapalli AV, Huang YA, et al
    Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020-December 2021.
    Emerg Infect Dis. 2023;29:1433-1437.
    PubMed     Abstract available


  70. RUDRAMURTHY SM, Singh S, Kanaujia R, Chaudhary H, et al
    Clinical and Mycologic Characteristics of Emerging Mucormycosis Agent Rhizopus homothallicus.
    Emerg Infect Dis. 2023;29:1313-1322.
    PubMed     Abstract available


  71. BIRAN R, Cohen R, Finn T, Brosh-Nissimov T, et al
    Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021-2022(1).
    Emerg Infect Dis. 2023;29:1297-1301.
    PubMed     Abstract available


    June 2023
  72. ROWE D, McDermott C, Veliz Y, Kerr A, et al
    Dengue Outbreak Response during COVID-19 Pandemic, Key Largo, Florida, USA, 2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  73. CHENG L, Dhiyebi HA, Varia M, Atanas K, et al
    Omicron COVID-19 Case Estimates Based on Previous SARS-CoV-2 Wastewater Load, Regional Municipality of Peel, Ontario, Canada.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  74. BERTRAM R, Hitzl W, Steinmann E, Steinmann J, et al
    Asymptomatic Healthcare Worker PCR Screening during SARS-CoV-2 Omicron Surge, Germany, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  75. MIYAHARA R, Tamura K, Kato T, Nakazaki M, et al
    SARS-CoV-2 Variants and Age-Dependent Infection Rates among Household and Nonhousehold Contacts.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  76. JACOB RA, Zhang A, Ajoge HO, D'Agostino MR, et al
    Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  77. OTAKE S, Ikenoue C, Sudani N, Kobayashi M, et al
    National Surveillance of Pediatric Acute Hepatitis of Unknown Etiology, Japan, October 2021-December 2022.
    Emerg Infect Dis. 2023;29:1288-1291.
    PubMed     Abstract available


  78. MEYER ZU NATRUP C, Schunemann LM, Saletti G, Clever S, et al
    MERS-CoV‒Specific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination.
    Emerg Infect Dis. 2023;29:1236-1239.
    PubMed     Abstract available


    May 2023
  79. FERRARI M, Di Marco L, Pivetti A, Paduano S, et al
    Long-Term SARS-CoV-2 Antibody Seroprevalence in Blood Donors, Italy.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  80. HAYNES JM, Dodd RY, Crowder LA, Notari EP, et al
    Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  81. BLOOMFIELD LE, Ngeh S, Cadby G, Hutcheon K, et al
    SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  82. TYSON GB, Jones S, Logan N, McDonald M, et al
    SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  83. GROENHEIT R, Bacchus P, Galanis I, Sonden K, et al
    High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  84. RODRIGUEZ-GRANDE C, Estevez A, Palomino-Cabrera R, Molero-Salinas A, et al
    Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  85. OKAFOR CM, Clogher P, Olson D, Niccolai L, et al
    Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015-2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  86. BAE J, Ro C, Kang Y, Ga E, et al
    Human-to-Animal Transmission of SARS-CoV-2, South Korea, 2021.
    Emerg Infect Dis. 2023;29:1066-1067.
    PubMed     Abstract available


    April 2023
  87. BARROSO-AREVALO S, Sanchez-Morales L, Barasona JA, Dominguez L, et al
    SARS-CoV-2 Seroprevalence Studies in Pets, Spain.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  88. SIEGRIST AA, Richardson KL, Ghai RR, Pope B, et al
    Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  89. TURNER S, Alisoltani A, Bratt D, Cohen-Lavi L, et al
    US National Institutes of Health Prioritization of SARS-CoV-2 Variants.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  90. BUSHMAKER T, Yinda CK, Morris DH, Holbrook MG, et al
    Comparative Aerosol and Surface Stability of SARS-CoV-2 Variants of Concern.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  91. ASAKURA T, Kimura T, Kurotori I, Kenichi K, et al
    Case-Control Study of Long COVID, Sapporo, Japan.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  92. GIDDING HF, Stepien S, Qian J, Macartney KK, et al
    COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  93. TAM NT, Anh NT, Tung TS, Thach PN, et al
    Spatiotemporal Evolution of SARS-CoV-2 Alpha and Delta Variants during Large Nationwide Outbreak of COVID-19, Vietnam, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  94. STAMOS DB, Barajas-Ochoa A, Raybould JE
    Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients.
    Emerg Infect Dis. 2023;29:696-700.
    PubMed     Abstract available


  95. ADU B, Bonney JHK, Egyir B, Otchere ID, et al
    SARS-CoV-2 Molecular Evolutionary Dynamics in the Greater Accra Region, Ghana.
    Emerg Infect Dis. 2023;29:862-865.
    PubMed     Abstract available


    March 2023
  96. PAMPATI S, Rasberry CN, Timpe Z, McConnell L, et al
    Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021-22 School Year.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  97. O'BRIEN SC, Cole LD, Albanese BA, Mahon A, et al
    SARS-CoV-2 Seroprevalence Compared with Confirmed COVID-19 Cases among Children, Colorado, USA, May-July 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  98. SHAO PL, Tu HC, Gong YN, Shu HY, et al
    Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  99. WILSON WW, Keaton AA, Ochoa LG, Hatfield KM, et al
    Outbreaks of SARS-CoV-2 Infections in Nursing Homes during Periods of Delta and Omicron Predominance, United States, July 2021-March 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  100. BISOFFI Z, De Santis N, Piubelli C, Deiana M, et al
    Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  101. SANTIAGO GA, Volkman HR, Flores B, Gonzalez GL, et al
    SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  102. GARCIA-GARCIA ML, Perez-Arenas E, Perez-Hernandez P, Falces-Romero I, et al
    Human Metapneumovirus Infections during COVID-19 Pandemic, Spain.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  103. GOYA S, Sereewit J, Pfalmer D, Nguyen TV, et al
    Genomic Characterization of Respiratory Syncytial Virus during 2022-23 Outbreak, Washington, USA.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  104. ZENG K, Santhya S, Soong A, Malhotra N, et al
    Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  105. GLATMAN-FREEDMAN A, Hershkovitz Y, Dichtiar R, Rosenberg A, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5-11 Years of Age, Israel.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  106. BUI VN, Dao TD, Tran LH, Vu TT, et al
    SARS-CoV-2 Infection in a Hippopotamus, Hanoi, Vietnam.
    Emerg Infect Dis. 2023;29:658-661.
    PubMed     Abstract available


  107. FARFOUR E, Zrounba M, Roux A, Revillet H, et al
    Inquilinus limosus Bacteremia in Lung Transplant Recipient after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2023;29:642-644.
    PubMed     Abstract available


  108. STOFFELLA-DUTRA AG, de Campos BH, Bastos E Silva PH, Dias KL, et al
    SARS-CoV-2 Spillback to Wild Coatis in Sylvatic-Urban Hotspot, Brazil.
    Emerg Infect Dis. 2023;29:664-667.
    PubMed     Abstract available


  109. RODON J, Mykytyn AZ, Te N, Okba NMA, et al
    Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain.
    Emerg Infect Dis. 2023;29:585-589.
    PubMed     Abstract available


    February 2023
  110. LYOO KS, Lee H, Lee SG, Yeom M, et al
    Experimental Infection and Transmission of SARS-CoV-2 Delta and Omicron Variants among Beagle Dogs.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  111. VEENSTRA T, van Schelven PD, Ten Have YM, Swaan CM, et al
    Extensive Spread of SARS-CoV-2 Delta Variant among Vaccinated Persons during 7-Day River Cruise, the Netherlands.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  112. NILLES EJ, de St Aubin M, Dumas D, Duke W, et al
    Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021-August 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  113. OGATA T, Tanaka H
    SARS-CoV-2 Incubation Period during the Omicron BA.5-Dominant Period in Japan.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  114. PASCO R, Johnson K, Fox SJ, Pierce KA, et al
    COVID-19 Test Allocation Strategy to Mitigate SARS-CoV-2 Infections across School Districts.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  115. LAGATHU G, Grolhier C, Besombes J, Maillard A, et al
    Using Discarded Facial Tissues to Monitor and Diagnose Viral Respiratory Infections.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  116. HEINRICH F, Huter T, Mertens S, Lange P, et al
    New Postmortem Perspective on Emerging SARS-CoV-2 Variants of Concern, Germany.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  117. KISLAYA I, Casaca P, Borges V, Sousa C, et al
    Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  118. SOTO RA, Baldry E, Vahey GM, Lehman J, et al
    Increase in Colorado Tick Fever Virus Disease Cases and Effect of COVID-19 Pandemic on Behaviors and Testing Practices, Montana, 2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  119. KISLAYA I, Melo A, Barreto M, Henriques C, et al
    Seroprevalence of Specific SARS-CoV-2 Antibodies during Omicron BA.5 Wave, Portugal, April-June 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  120. LIU D, Cheng Y, Zhou H, Wang L, et al
    Early Introduction and Community Transmission of SARS-CoV-2 Omicron Variant, New York, New York, USA.
    Emerg Infect Dis. 2023;29:371-380.
    PubMed     Abstract available


  121. KHOURY DS, Schlub TE, Cromer D, Steain M, et al
    Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection.
    Emerg Infect Dis. 2023;29:381-388.
    PubMed     Abstract available


  122. OYGAR PD, Gurlevik SL, Sag E, Ilbay S, et al
    Changing Disease Course of Crimean-Congo Hemorrhagic Fever in Children, Turkey.
    Emerg Infect Dis. 2023;29:268-277.
    PubMed     Abstract available


    January 2023
  123. LANDRY M, Bornstein S, Nagaraj N, Sardon GA Jr, et al
    Postacute Sequelae of SARS-CoV-2 in University Setting.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  124. ELLINGSON KD, Hollister J, Porter CJ, Khan SM, et al
    Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  125. XIONG W, Peng L, Tsang TK, Cowling BJ, et al
    Epidemiology of SARS-CoV-2 Omicron BA.5 Infections, Macau, June-July 2022.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  126. JEON S, Rainisch G, Harris AM, Shinabery J, et al
    Estimated Cases Averted by COVID-19 Digital Exposure Notification, Pennsylvania, USA, November 8, 2020-January 2, 2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  127. OFORI SK, Schwind JS, Sullivan KL, Chowell G, et al
    Age-Stratified Model to Assess Health Outcomes of COVID-19 Vaccination Strategies, Ghana.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  128. SHAFER L, Ahmed F, Kim S, Wernli KJ, et al
    Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  129. OLTEAN HN, Allen KJ, Frisbie L, Lunn SM, et al
    Sentinel Surveillance System Implementation and Evaluation for SARS-CoV-2 Genomic Data, Washington, USA, 2020-2021.
    Emerg Infect Dis. 2023;29.
    PubMed     Abstract available


  130. ZAIDI A, Harris R, Hall J, Woodhall S, et al
    Effects of Second Dose of SARS-CoV-2 Vaccination on Household Transmission, England.
    Emerg Infect Dis. 2023;29:127-132.
    PubMed     Abstract available


  131. MUGISHA J, Mpairwe B, Newton R, Cotten M, et al
    SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda.
    Emerg Infect Dis. 2023;29:224-226.
    PubMed     Abstract available


  132. CURTIS SJ, Shah AW, Ratu A, Wilson DJ, et al
    Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021.
    Emerg Infect Dis. 2023;29:226-228.
    PubMed     Abstract available


  133. DEWITT ME, Tjaden AH, Herrington D, Schieffelin J, et al
    COVID-19 Symptoms by Variant Period in the North Carolina COVID-19 Community Research Partnership, North Carolina, USA.
    Emerg Infect Dis. 2023;29:207-211.
    PubMed     Abstract available


  134. MUTHU V, Agarwal R, Rudramurthy SM, Thangaraju D, et al
    Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India.
    Emerg Infect Dis. 2023;29:8-19.
    PubMed    


  135. KOKS-LEENSEN MCJ, Schalk BWM, Bakker-van Gijssel EJ, Timen A, et al
    Risk for Severe COVID-19 Outcomes among Persons with Intellectual Disabilities, the Netherlands.
    Emerg Infect Dis. 2023;29:118-126.
    PubMed     Abstract available


  136. MUNYEKU-BAZITAMA Y, Folefack GT, Yambayamba MK, Tshiminyi PM, et al
    High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020-April 2021), Democratic Republic of the Congo.
    Emerg Infect Dis. 2023;29:89-97.
    PubMed     Abstract available


  137. LEUNG C, Su L, Simoes-E-Silva AC, Arocha LS, et al
    Risk for Severe Illness and Death among Pediatric Patients with Down Syndrome Hospitalized for COVID-19, Brazil.
    Emerg Infect Dis. 2023;29:26-35.
    PubMed     Abstract available


  138. ROE MK, Huffman ER, Batista YS, Papadeas GG, et al
    Comprehensive Review of Emergence and Virology of Tickborne Bourbon Virus in the United States.
    Emerg Infect Dis. 2023;29:1-7.
    PubMed     Abstract available


    December 2022
  139. CLICK ES, Malec D, Chevinsky J, Tao G, et al
    Longitudinal Analysis of Electronic Health Information to Identify Possible COVID-19 Sequelae.
    Emerg Infect Dis. 2022;29.
    PubMed     Abstract available


  140. LU PJ, Srivastav A, Vashist K, Black CL, et al
    COVID-19 Booster Dose Vaccination Coverage and Factors associated with Booster Vaccination among Adults, United States, March 2022.
    Emerg Infect Dis. 2022;29.
    PubMed     Abstract available


  141. MURAKAMI S, Kitamura T, Matsugo H, Kamiki H, et al
    Isolation of Bat Sarbecoviruses, Japan.
    Emerg Infect Dis. 2022;28:2500-2503.
    PubMed     Abstract available


  142. EARNEST R, Chen C, Chaguza C, Hahn AM, et al
    Daily Rapid Antigen Exit Testing to Tailor University COVID-19 Isolation Policy.
    Emerg Infect Dis. 2022;28:2455-2462.
    PubMed     Abstract available


  143. FOULKES S, Monk EJM, Sparkes D, Hettiarachchi N, et al
    Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022.
    Emerg Infect Dis. 2022;29.
    PubMed     Abstract available


  144. KIMANI D, Ndegwa L, Njeru M, Wesangula E, et al
    Adopting World Health Organization Multimodal Infection Prevention and Control Strategies to Respond to COVID-19, Kenya.
    Emerg Infect Dis. 2022;28:S247-S254.
    PubMed     Abstract available


  145. BOBO P, Hines JZ, Chilengi R, Auld AF, et al
    Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia.
    Emerg Infect Dis. 2022;28:S244-S246.
    PubMed     Abstract available


  146. PECK ME, Ong KS, Lucas T, Prainito A, et al
    Effects of COVID-19 Pandemic on Voluntary Medical Male Circumcision Services for HIV Prevention, Sub-Saharan Africa, 2020.
    Emerg Infect Dis. 2022;28:S262-S269.
    PubMed     Abstract available


  147. ARRIOLA CS, Soto G, Westercamp M, Bollinger S, et al
    Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru.
    Emerg Infect Dis. 2022;28:S238-S243.
    PubMed     Abstract available


  148. IHEKWEAZU C
    Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S299-S301.
    PubMed     Abstract available


  149. MARCENAC P, McCarron M, Davis W, Igboh LS, et al
    Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S26-S33.
    PubMed     Abstract available


  150. OCHIENG W, Sage EO, Achia T, Oluoch P, et al
    Sexual Violence Trends before and after Rollout of COVID-19 Mitigation Measures, Kenya.
    Emerg Infect Dis. 2022;28:S270-S276.
    PubMed     Abstract available


  151. OLSON D, Calvimontes DM, Lamb MM, Guzman G, et al
    Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala(1).
    Emerg Infect Dis. 2022;28:S277-S287.
    PubMed     Abstract available


  152. AHERON S, Victory KR, Imtiaz A, Fellows I, et al
    A Nationally Representative Survey of COVID-19 in Pakistan, 2021-2022.
    Emerg Infect Dis. 2022;28:S69-S75.
    PubMed     Abstract available


  153. KINKADE C, Russpatrick S, Potter R, Saebo J, et al
    Extending and Strengthening Routine DHIS2 Surveillance Systems for COVID-19 Responses in Sierra Leone, Sri Lanka, and Uganda.
    Emerg Infect Dis. 2022;28:S42-S48.
    PubMed     Abstract available


  154. MIRZA M, Grant-Greene Y, Valles MPJS, Joseph P, et al
    Leveraging PEPFAR-Supported Health Information Systems for COVID-19 Pandemic Response.
    Emerg Infect Dis. 2022;28:S49-S58.
    PubMed     Abstract available


  155. SHIH DC, Silver R, Henao OL, Alemu A, et al
    Incorporating COVID-19 into Acute Febrile Illness Surveillance Systems, Belize, Kenya, Ethiopia, Peru, and Liberia, 2020-2021.
    Emerg Infect Dis. 2022;28:S34-S41.
    PubMed     Abstract available


  156. SHRAGAI T, Talley L, Summers A, Behringer H, et al
    Outcomes after Acute Malnutrition Program Adaptations to COVID-19, Uganda, Ethiopia, and Somalia.
    Emerg Infect Dis. 2022;28:S288-S298.
    PubMed     Abstract available


  157. ROMANO ER, Sleeman K, Hall-Eidson P, Zeh C, et al
    Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries.
    Emerg Infect Dis. 2022;28:S59-S68.
    PubMed     Abstract available


  158. THEU JA, Kabaghe AN, Bello G, Chitsa-Banda E, et al
    SARS-CoV-2 Prevalence in Malawi Based on Data from Survey of Communities and Health Workers in 5 High-Burden Districts, October 2020.
    Emerg Infect Dis. 2022;28:S76-S84.
    PubMed     Abstract available


  159. RICKS PM, Njie GJ, Dawood FS, Blain AE, et al
    Lessons Learned from CDC's Global COVID-19 Early Warning and Response Surveillance System.
    Emerg Infect Dis. 2022;28:S8-S16.
    PubMed     Abstract available


  160. OHLSEN EC, Hawksworth AW, Wong K, Guagliardo SAJ, et al
    Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions.
    Emerg Infect Dis. 2022;28:S85-S92.
    PubMed     Abstract available


  161. CASSELL CH, Raghunathan PL, Henao O, Pappas-DeLuca KA, et al
    Global Responses to the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:S4-S7.
    PubMed    


  162. AMPONSA-ACHIANO K, Frimpong JA, Barradas D, Bandoh DA, et al
    Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021.
    Emerg Infect Dis. 2022;28:S232-S237.
    PubMed     Abstract available


  163. BIGOUETTE JP, Callaghan AW, Donadel M, Porter AM, et al
    Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020.
    Emerg Infect Dis. 2022;28:S203-S207.
    PubMed     Abstract available


  164. DIXON MG, Reef SE, Zimmerman LA, Grant GB, et al
    Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.
    Emerg Infect Dis. 2022;28:S225-S231.
    PubMed     Abstract available


  165. HERMAN-ROLOFF A, Aman R, Samandari T, Kasera K, et al
    Adapting Longstanding Public Health Collaborations between Government of Kenya and CDC Kenya in Response to the COVID-19 Pandemic, 2020-2021.
    Emerg Infect Dis. 2022;28:S159-S167.
    PubMed     Abstract available


  166. MERRILL RD, Kilamile F, White M, Eurien D, et al
    Using Population Mobility Patterns to Adapt COVID-19 Response Strategies in 3 East Africa Countries.
    Emerg Infect Dis. 2022;28:S105-S113.
    PubMed     Abstract available


  167. GOMES DJ, Hazim C, Safstrom J, Herzig C, et al
    Infection Prevention and Control Initiatives to Prevent Healthcare-Associated Transmission of SARS-CoV-2, East Africa.
    Emerg Infect Dis. 2022;28:S255-S261.
    PubMed     Abstract available


  168. KABORE HJ, Li X, Allison RD, Avagyan T, et al
    Effects of Decreased Immunization Coverage for Hepatitis B Virus Caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020.
    Emerg Infect Dis. 2022;28:S217-S224.
    PubMed     Abstract available


  169. SMITH-SREEN J, Miller B, Kabaghe AN, Kim E, et al
    Comparison of COVID-19 Pandemic Waves in 10 Countries in Southern Africa, 2020-2021.
    Emerg Infect Dis. 2022;28:S93-S104.
    PubMed     Abstract available


  170. SINGH SK, Dikid T, Dhuria M, Bahl A, et al
    India Field Epidemiology Training Program Response to COVID-19 Pandemic, 2020-2021.
    Emerg Infect Dis. 2022;28:S138-S144.
    PubMed     Abstract available


  171. DOKUBO EK, Shang JD, N'Dir A, Ndongmo CB, et al
    Building on Capacity Established through US Centers for Disease Control and Prevention Global Health Programs to Respond to COVID-19, Cameroon.
    Emerg Infect Dis. 2022;28:S181-S190.
    PubMed     Abstract available


  172. ERICKSON-MAMANE L, Kryshchuk A, Gvozdetska O, Rossovskyi D, et al
    Faith Community Engagement to Mitigate COVID-19 Transmission Associated with Mass Gathering, Uman, Ukraine, September 2021.
    Emerg Infect Dis. 2022;28:S197-S202.
    PubMed     Abstract available


  173. KENU E, Barradas DT, Bandoh DA, Frimpong JA, et al
    Community-Based Surveillance and Geographic Information System‒Linked Contact Tracing in COVID-19 Case Identification, Ghana, March‒June 2020.
    Emerg Infect Dis. 2022;28:S114-S120.
    PubMed     Abstract available


  174. BOLU O, Mustapha B, Ihekweazu C, Muhammad M, et al
    Effect of Nigeria Presidential Task Force on COVID-19 Pandemic, Nigeria.
    Emerg Infect Dis. 2022;28:S168-S176.
    PubMed     Abstract available


  175. CHIOU H, Voegeli C, Wilhelm E, Kolis J, et al
    The Future of Infodemic Surveillance as Public Health Surveillance.
    Emerg Infect Dis. 2022;28:S121-S128.
    PubMed     Abstract available


  176. ZUBER A, Sebeh Y, Jarvis D, Bratton S, et al
    Exploratory Literature Review of the Role of National Public Health Institutes in COVID-19 Response.
    Emerg Infect Dis. 2022;28:S151-S158.
    PubMed     Abstract available


  177. BELL E, Mittendorf C, Meyer E, Barnum O, et al
    Continuing Contributions of Field Epidemiology Training Programs to Global COVID-19 Response.
    Emerg Infect Dis. 2022;28:S129-S137.
    PubMed     Abstract available


  178. WRIGHT J, Tison L, Chun H, Gutierrez C, et al
    Use of Project ECHO in Response to COVID-19 in Countries Supported by US President's Emergency Plan for AIDS Relief.
    Emerg Infect Dis. 2022;28:S191-S196.
    PubMed     Abstract available


  179. KNUST B, Wongjindanon N, Moe AA, Herath L, et al
    Enhancing Respiratory Disease Surveillance to Detect COVID-19 in Shelters for Displaced Persons, Thailand-Myanmar Border, 2020-2021.
    Emerg Infect Dis. 2022;28:S17-S25.
    PubMed     Abstract available


  180. SOETERS HM, Doshi RH, Fleming M, Adegoke OJ, et al
    CDC's COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions.
    Emerg Infect Dis. 2022;28:S208-S216.
    PubMed     Abstract available


  181. TABACK-ESRA R, Morof D, Briggs-Hagen M, Savva H, et al
    Use of Epidemiology Surge Support to Enhance Robustness and Expand Capacity of SARS-CoV-2 Pandemic Response, South Africa.
    Emerg Infect Dis. 2022;28:S177-S180.
    PubMed     Abstract available


  182. KRISHNAN S, Espinosa C, Podgornik MN, Haile S, et al
    COVID-19 Response Roles among CDC International Public Health Emergency Management Fellowship Graduates.
    Emerg Infect Dis. 2022;28:S145-S150.
    PubMed     Abstract available


  183. WALENSKY RP
    Partnerships, Collaborations, and Investments Integral to CDC's International Response to COVID-19.
    Emerg Infect Dis. 2022;28:S1-S3.
    PubMed    


    November 2022
  184. PEDERSEN RM, Bang LL, Tornby DS, Madsen LW, et al
    Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  185. WEI HY, Chang CP, Liu MT, Mu JJ, et al
    Probable Aerosol Transmission of SARS-CoV-2 through Floors and Walls of Quarantine Hotel, Taiwan, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  186. BOURRET V, Dutra L, Alburkat H, Maki S, et al
    Serologic Surveillance for SARS-CoV-2 Infection among Wild Rodents, Europe.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  187. THOMAS GR, Corso A, Pasteran F, Shal J, et al
    Increased Detection of Carbapenemase-Producing Enterobacterales Bacteria in Latin America and the Caribbean during the COVID-19 Pandemic.
    Emerg Infect Dis. 2022;28:1-8.
    PubMed     Abstract available


  188. QUINTERO AM, Eisner M, Sayegh R, Wright T, et al
    Differences in SARS-CoV-2 Clinical Manifestations and Disease Severity in Children and Adolescents by Infecting Variant.
    Emerg Infect Dis. 2022;28:2270-2280.
    PubMed     Abstract available


    October 2022
  189. MEISNER J, Baszler TV, Kuehl KE, Ramirez V, et al
    Household Transmission of SARS-CoV-2 from Humans to Pets, Washington and Idaho, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  190. CIRUELA P, Soldevila N, Garcia-Garcia JJ, Gonzalez-Peris S, et al
    Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  191. LI Y, Merbah M, Wollen-Roberts S, Beckman B, et al
    Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  192. ROEL E, Raventos B, Burn E, Pistillo A, et al
    Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  193. NYAKARAHUKA L, Whitmer S, Kyondo J, Mulei S, et al
    Crimean-Congo Hemorrhagic Fever Outbreak in Refugee Settlement during COVID-19 Pandemic, Uganda, April 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  194. YAMAYOSHI S, Iwatsuki-Horimoto K, Okuda M, Ujie M, et al
    Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  195. SODSAI P, Ittiwut C, Ruenjaiman V, Ittiwut R, et al
    TIGIT Monoallelic Nonsense Variant in Patient with Severe COVID-19 Infection, Thailand.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  196. BAZ M, Deshpande N, Mackenzie-Kludas C, Mordant F, et al
    SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  197. ROBERTSON MM, Shamsunder MG, Brazier E, Mantravadi M, et al
    Racial/Ethnic Disparities in Exposure, Disease Susceptibility, and Clinical Outcomes during COVID-19 Pandemic in National Cohort of Adults, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  198. VALLEJOS A, Baldani AEM, Gauto MA, Rueda DV, et al
    COVID-19 among Chronic Dialysis Patients after First Year of Pandemic, Argentina.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  199. KIM YY, Choe YJ, Kim J, Kim RK, et al
    Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  200. GASCH O, Badia-Cebada L, Carmezim J, Vaque M, et al
    Effects of the COVID-19 Pandemic on Incidence and Epidemiology of Catheter-Related Bacteremia, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  201. VALTONEN M, Waris M, Luoto R, Mjosund K, et al
    Non-SARS-CoV-2 Respiratory Viruses in Athletes at Major Winter Sport Events, 2021 and 2022.
    Emerg Infect Dis. 2022;28:2096-2099.
    PubMed     Abstract available


  202. AKHMETZHANOV AR, Cheng HY, Linton NM, Ponce L, et al
    Transmission Dynamics and Effectiveness of Control Measures during COVID-19 Surge, Taiwan, April-August 2021.
    Emerg Infect Dis. 2022;28:2051-2059.
    PubMed     Abstract available


    September 2022
  203. MARTINS-MELO FR, Castro MC, Ribeiro ALP, Heukelbach J, et al
    Deaths Related to Chagas Disease and COVID-19 Co-Infection, Brazil, March-December 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  204. LEWIS JW, Loughran J, Deng L, Varghese J, et al
    Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  205. NGUYEN NN, Houhamdi L, Delorme L, Colson P, et al
    Reinfections with Different SARS-CoV-2 Omicron Subvariants, France.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  206. CHOW EJ, Casto AM, Sampoleo R, Mills MG, et al
    Human Parainfluenza Virus in Homeless Shelters before and during the COVID-19 Pandemic, Washington, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  207. COSSABOOM CM, Nyakarahuka L, Mulei S, Kyondo J, et al
    Rift Valley Fever Outbreak during COVID-19 Surge, Uganda, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  208. FUKASAWA LO, Liphaus BL, Goncalves MG, Higa FT, et al
    Invasive Meningococcal X Disease during the COVID-19 Pandemic, Brazil.
    Emerg Infect Dis. 2022;28:1931-1932.
    PubMed     Abstract available


  209. KEYEL AC, Russell A, Plitnick J, Rowlands JV, et al
    SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  210. CHAN DPC, Wong NS, Wong BCK, Chan JMC, et al
    Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  211. WOLFENSBERGER A, Kufner V, Zaheri M, Zeeb M, et al
    Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    August 2022
  212. LOPEZ-MUNOZ I, Torrella A, Lopez-Quilez O, Castillo-Zuza A, et al
    SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  213. SIM JY, Wu PS, Cheng CF, Chao YC, et al
    Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  214. SHAH MM, Winn A, Dahl RM, Kniss KL, et al
    Seasonality of Common Human Coronaviruses, United States, 2014-2021(1).
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  215. ZEEB M, Weissberg D, Rampini SK, Muller R, et al
    Identifying Contact Risks for SARS-CoV-2 Transmission to Healthcare Workers during Outbreak on COVID-19 Ward.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  216. BLOM K, Havervall S, Marking U, Norin NG, et al
    Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  217. RUFF J, Zhang Y, Kappel M, Rathi S, et al
    Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  218. MUNNINK BBO, Nijhuis RHT, Worp N, Boter M, et al
    Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  219. BERTRAN M, Amin-Chowdhury Z, Sheppard CL, Eletu S, et al
    Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England.
    Emerg Infect Dis. 2022;28:1669-1672.
    PubMed     Abstract available


  220. SEID AG, Yirko T, Sayeed S, Plipat N, et al
    Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  221. MEFSIN YM, Chen D, Bond HS, Lin Y, et al
    Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January-March 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  222. ALLAN-BLITZ LT, Aboabdo B, Turner I, Klausner JD, et al
    Effect of Frequent SARS-CoV-2 Testing on Weekly Case Rates in Long-Term Care Facilities, Florida, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  223. HE D, Ali ST, Fan G, Gao D, et al
    Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  224. WERNIKE K, Bottcher J, Amelung S, Albrecht K, et al
    Antibodies against SARS-CoV-2 Suggestive of Single Events of Spillover to Cattle, Germany.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    July 2022
  225. NORZ D, Tang HT, Emmerich P, Giersch K, et al
    Rapid Adaptation of Established High-Throughput Molecular Testing Infrastructure for Monkeypox Virus Detection.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  226. LOESCHE M, Karlson EW, Talabi O, Zhou G, et al
    Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  227. HUBERT CRJ, Acosta N, Waddell BJM, Hasing ME, et al
    Tracking Emergence and Spread of SARS-CoV-2 Omicron Variant in Large and Small Communities by Wastewater Monitoring in Alberta, Canada.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  228. KAYA D, Falender R, Radniecki T, Geniza M, et al
    Correlation between Clinical and Wastewater SARS-CoV-2 Genomic Surveillance, Oregon, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  229. PORTER SM, Hartwig AE, Bielefeldt-Ohmann H, Bosco-Lauth AM, et al
    Susceptibility of Wild Canids to SARS-CoV-2.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  230. DE OLIVEIRA-FILHO EF, Rincon-Orozco B, Jones-Cifuentes N, Pena-Lopez B, et al
    Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  231. KO YK, Murayama H, Yamasaki L, Kinoshita R, et al
    Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  232. MENG L, Murthy NC, Murthy BP, Zell E, et al
    Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  233. LIM DS, Choe YJ, Man Kim Y, Lee SE, et al
    Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  234. LIN S, Deng X, Ryan I, Zhang K, et al
    COVID-19 Symptoms and Deaths among Healthcare Workers, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  235. DE VRIES M, Claassen L, Lambooij M, Leung KY, et al
    COVID-19 Vaccination Intent and Belief that Vaccination Will End the Pandemic.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  236. ARASHIRO T, Arima Y, Stucky A, Smith C, et al
    Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  237. KIM JM, Sivasubramanian G
    Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids.
    Emerg Infect Dis. 2022;28:1531-1533.
    PubMed     Abstract available


  238. KOYAMA AK, Koumans EH, Sircar K, Lavery AM, et al
    Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States.
    Emerg Infect Dis. 2022;28:1533-1536.
    PubMed     Abstract available


  239. SILVERMAN RA, Ceci A, Cohen A, Helmick M, et al
    Vaccine Effectiveness during Outbreak of COVID-19 Alpha (B.1.1.7) Variant in Men's Correctional Facility, United States.
    Emerg Infect Dis. 2022;28:1313-1320.
    PubMed     Abstract available


    June 2022
  240. NEVEJAN L, Cuypers L, Laenen L, Van Loo L, et al
    Early SARS-CoV-2 Reinfections within 60 Days and Implications for Retesting Policies.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  241. KREMER C, Braeye T, Proesmans K, Andre E, et al
    Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19-December 31, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  242. MAGRO M, Parriott A, Mitsunaga T, Epson E, et al
    Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  243. MATSUMURA Y, Nagao M, Yamamoto M, Tsuchido Y, et al
    Transmissibility of SARS-CoV-2 B.1.1.214 and Alpha Variants during 4 COVID-19 Waves, Kyoto, Japan, January 2020-June 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  244. METZ AR, Bauer M, Epperly C, Stringer G, et al
    Investigation of COVID-19 Outbreak among Wildland Firefighters during Wildfire Response, Colorado, USA, 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  245. DAOUK SK, Kamau E, Adachi K, Aldrovandi GM, et al
    Zoster Meningitis in an Immunocompetent Child after COVID-19 Vaccination, California, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  246. SILA T, Sunghan J, Laochareonsuk W, Surasombatpattana S, et al
    Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July-September 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  247. MOFAZ M, Yechezkel M, Guan G, Brandeau ML, et al
    Self-Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  248. FOWLE N, Garrett B, Floyd OL, Collins J, et al
    University-Associated SARS-CoV-2 Omicron BA.2 Infections, Maricopa County, Arizona, USA, 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  249. VIRTANEN J, Aaltonen K, Kegler K, Venkat V, et al
    Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease.
    Emerg Infect Dis. 2022;28:1286-1288.
    PubMed     Abstract available


  250. BIENZLE D, Rousseau J, Marom D, MacNicol J, et al
    Risk Factors for SARS-CoV-2 Infection and Illness in Cats and Dogs(1).
    Emerg Infect Dis. 2022;28:1154-1162.
    PubMed     Abstract available


  251. SPENCER H, Teran RA, Barbian HJ, Love S, et al
    Multistate Outbreak of Infection with SARS-CoV-2 Omicron Variant after Event in Chicago, Illinois, USA, 2021.
    Emerg Infect Dis. 2022;28:1281-1283.
    PubMed     Abstract available


    May 2022
  252. SOFONEA MT, Roquebert B, Foulongne V, Morquin D, et al
    Analyzing and Modeling the Spread of SARS-CoV-2 Omicron Lineages BA.1 and BA.2, France, September 2021-February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  253. LEEMAN D, Flannagan J, Chudasama D, Dack K, et al
    Effect of Returning University Students on COVID-19 Infections in England, 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  254. COLE LD, Slate M, Minneman S, Bozzella MJ, et al
    Multisystem Inflammatory Syndrome after Breakthrough SARS-CoV-2 Infection in 2 Immunized Adolescents, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  255. SHIRREFF G, Zahar JR, Cauchemez S, Temime L, et al
    Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  256. LACEK KA, Rambo-Martin BL, Batra D, Zheng XY, et al
    SARS-CoV-2 Delta-Omicron Recombinant Viruses, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  257. CHIN AWH, Lai AMY, Peiris M, Man Poon LL, et al
    Increased Stability of SARS-CoV-2 Omicron Variant over Ancestral Strain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  258. FOURATI S, Gautier G, Chovelon M, Soulier A, et al
    Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  259. FOCOSI D, Casadevall A
    High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
    Emerg Infect Dis. 2022;28:1083.
    PubMed    


  260. MOSER W, Fahal MAH, Abualas E, Bedri S, et al
    SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan.
    Emerg Infect Dis. 2022;28:1026-1030.
    PubMed     Abstract available


  261. GRASSIA JT, Markwalter CF, O'Meara WP, Taylor SM, et al
    SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia.
    Emerg Infect Dis. 2022;28:1080-1081.
    PubMed    


  262. DE SANTIS GC, Calado RT
    High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response).
    Emerg Infect Dis. 2022;28:1083-1084.
    PubMed    


  263. FINSTERER J, Scorza FA, Scorza CA
    Guillain-Barre Syndrome Associated with COVID-19 Vaccination.
    Emerg Infect Dis. 2022;28:1079-1080.
    PubMed    


    April 2022
  264. HOGARTH F, Coffey P, Goddard L, Lewis S, et al
    Genomic Evidence of In-Flight SARS-CoV-2 Transmission, India to Australia, April 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  265. HARRIS JR, Owusu D, O'Laughlin K, Cohen AL, et al
    SARS-CoV-2 Breakthrough Infections among US Embassy Staff Members, Uganda, May-June 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  266. NDONGO FA, Guichet E, Mimbe ED, Ndie J, et al
    Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaounde, Cameroon.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  267. SATO T, Kodama S, Kaneko K, Imai J, et al
    Type 1 Diabetes Mellitus Associated with Nivolumab after Second SARS-CoV-2 Vaccination, Japan.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  268. SUTTON M, Radniecki TS, Kaya D, Alegre D, et al
    Detection of SARS-CoV-2 B.1.351 (Beta) Variant through Wastewater Surveillance before Case Detection in a Community, Oregon, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  269. FONSECA MHG, Pinto ACMD, Silva MFS, de Melo ACL, et al
    Dynamics of SARS-CoV-2 Antibody Response to CoronaVac followed by Booster Dose of BNT162b2 Vaccine.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  270. NOVAZZI F, Baj A, Genoni A, Focosi D, et al
    Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  271. GU H, Ng DYM, Liu GYZ, Cheng SSM, et al
    Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  272. DEL AGUILA-MEJIA J, Wallmann R, Calvo-Montes J, Rodriguez-Lozano J, et al
    Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  273. VAUHKONEN H, Nguyen PT, Kant R, Plyusnin I, et al
    Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  274. MERCIER A, Wilkinson DA, Lebarbenchon C, Mavingui P, et al
    Spread of SARS-CoV-2 Variants on Reunion Island, France, 2021.
    Emerg Infect Dis. 2022;28:895-898.
    PubMed     Abstract available


  275. LEE HR, Choe YJ, Jang EJ, Kim J, et al
    Time from Exposure to Diagnosis among Quarantined Close Contacts of SARS-CoV-2 Omicron Variant Index Case-Patients, South Korea.
    Emerg Infect Dis. 2022;28:901-903.
    PubMed     Abstract available


  276. GROME HN, Meyer B, Read E, Buchanan M, et al
    SARS-CoV-2 Outbreak among Malayan Tigers and Humans, Tennessee, USA, 2020.
    Emerg Infect Dis. 2022;28:833-836.
    PubMed     Abstract available


  277. WINGLEE K, Hill AN, Langer AJ, Self JL, et al
    Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020.
    Emerg Infect Dis. 2022;28:820-827.
    PubMed     Abstract available


  278. BEN LAKHAL H, Cachinho JB, Kalfon P, Naas T, et al
    Bordetella hinzii Pneumonia in Patient with SARS-CoV-2 Infection.
    Emerg Infect Dis. 2022;28:844-847.
    PubMed     Abstract available


  279. RASMUSSEN LD, Richter SR, Midgley SE, Franck KT, et al
    Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  280. GLATMAN-FREEDMAN A, Bromberg M, Hershkovitz Y, Sefty H, et al
    Effectiveness of BNT162b2 Vaccine Booster against SARS-CoV-2 Infection and Breakthrough Complications, Israel.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


    March 2022
  281. PEDERSEN RM, Bang LL, Madsen LW, Sydenham TV, et al
    Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  282. YU AT, Hughes B, Wolfe MK, Leon T, et al
    Estimating Relative Abundance of 2 SARS-CoV-2 Variants through Wastewater Surveillance at 2 Large Metropolitan Sites, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  283. JENNY-AVITAL ER, Howe RA
    Severe Multisystem Inflammatory Symptoms in 2 Adults after Short Interval between COVID-19 and Subsequent Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  284. KLEYNHANS J, Tempia S, Wolter N, von Gottberg A, et al
    SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  285. BBOSA N, Ssemwanga D, Namagembe H, Kiiza R, et al
    Rapid Replacement of SARS-CoV-2 Variants by Delta and Subsequent Arrival of Omicron, Uganda, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  286. TAKAHASHI K, Ishikane M, Ujiie M, Iwamoto N, et al
    Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  287. JAIN E, Donowitz JR, Aarons E, Marshall BC, et al
    Multisystem Inflammatory Syndrome in Children after SARS-CoV-2 Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  288. KOOPSEN J, van Ewijk CE, Bavalia R, Cornelissen A, et al
    Epidemiologic and Genomic Analysis of SARS-CoV-2 Delta Variant Superspreading Event in Nightclub, the Netherlands, June 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  289. VAN GEMERT C, Tarivonda L, Tapo PS, Natuman S, et al
    Mathematical Modeling for Removing Border Entry and Quarantine Requirements for COVID-19, Vanuatu.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  290. TOBER-LAU P, Gruell H, Vanshylla K, Koch WM, et al
    Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  291. MITCHELL HD, Vilaplana TG, Mandal S, Ratna N, et al
    Effects of COVID-19 Pandemic Response on Service Provision for Sexually Transmitted Infections, HIV, and Viral Hepatitis, England.
    Emerg Infect Dis. 2022;28:739-742.
    PubMed     Abstract available


  292. HO F, Tsang TK, Gao H, Xiao J, et al
    Restaurant-Based Measures to Control Community Transmission of COVID-19, Hong Kong.
    Emerg Infect Dis. 2022;28:759-761.
    PubMed     Abstract available


  293. CURRIE DW, Shah MM, Salvatore PP, Ford L, et al
    Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures.
    Emerg Infect Dis. 2022;28:717-720.
    PubMed     Abstract available


  294. YI S, Choe YJ, Kim J, Kim YY, et al
    SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021.
    Emerg Infect Dis. 2022;28:753-756.
    PubMed     Abstract available


  295. HASAN T, Nguyen VN, Nguyen HB, Nguyen TA, et al
    Retrospective Cohort Study of Effects of the COVID-19 Pandemic on Tuberculosis Notifications, Vietnam, 2020.
    Emerg Infect Dis. 2022;28:684-692.
    PubMed     Abstract available


  296. STONE M, Grebe E, Sulaeman H, Di Germanio C, et al
    Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications.
    Emerg Infect Dis. 2022;28:672-683.
    PubMed     Abstract available


  297. NGUYEN KH, Huang J, Mansfield K, Corlin L, et al
    COVID-19 Vaccination Coverage, Behaviors, and Intentions among Adults with Previous Diagnosis, United States.
    Emerg Infect Dis. 2022;28:631-638.
    PubMed     Abstract available


  298. SPRECO A, Joud A, Eriksson O, Soltesz K, et al
    Nowcasting (Short-Term Forecasting) of COVID-19 Hospitalizations Using Syndromic Healthcare Data, Sweden, 2020.
    Emerg Infect Dis. 2022;28:564-571.
    PubMed     Abstract available


  299. ERBER J, Kappler V, Haller B, Mijocevic H, et al
    Infection Control Measures and Prevalence of SARS-CoV-2 IgG among 4,554 University Hospital Employees, Munich, Germany.
    Emerg Infect Dis. 2022;28:572-581.
    PubMed     Abstract available


  300. DEL CURA-BILBAO A, Lopez-Mendoza H, Chaure-Pardos A, Vergara-Ugarriza A, et al
    Effectiveness of 3 COVID-19 Vaccines in Preventing SARS-CoV-2 Infections, January-May 2021, Aragon, Spain.
    Emerg Infect Dis. 2022;28:591-598.
    PubMed     Abstract available


    February 2022
  301. MURTHY NC, Zell E, Fast HE, Murthy BP, et al
    Disparities in First Dose COVID-19 Vaccination Coverage among Children 5-11 Years of Age, United States.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  302. GRIFFIN I, Woodworth KR, Galang RR, Burkel VK, et al
    Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  303. PONS-SALORT M, John J, Watson OJ, Brazeau NF, et al
    Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  304. DULOVIC A, Strengert M, Ramos GM, Becker M, et al
    Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  305. RAGHWANI J, du Plessis L, McCrone JT, Hill SC, et al
    Genomic Epidemiology of Early SARS-CoV-2 Transmission Dynamics, Gujarat, India.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  306. LAING ED, Weiss CD, Samuels EC, Coggins SA, et al
    Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  307. COELHO RM, Periolo N, Duhalde CP, Alonso DO, et al
    Hantavirus Pulmonary Syndrome in a COVID-19 Patient, Argentina, 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  308. ZAYET S, Gendrin V, Gay C, Selles P, et al
    Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  309. CHAVES DG, Takahashi RHC, Campelo F, da Silva Malta MCF, et al
    SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  310. BONGUILI NCB, Fritz M, Lenguiya H, Mayengue PI, et al
    Early Circulation of SARS-CoV-2, Congo, 2020.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  311. KIM EY, Choe YJ, Park H, Jeong H, et al
    Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  312. MIYAZATO Y, Yamamoto K, Yamada G, Kubota S, et al
    Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  313. REAGAN-STEINER S, Bhatnagar J, Martines RB, Milligan NS, et al
    Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  314. RUSSELL A, O'Connor C, Lasek-Nesselquist E, Plitnick J, et al
    Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  315. BONIFACIO LP, Csizmar VNF, Barbosa-Junior F, Pereira APS, et al
    Long-Term Symptoms among COVID-19 Survivors in Prospective Cohort Study, Brazil.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  316. HEGUY A, Dimartino D, Marier C, Zappile P, et al
    Amplification Artifact in SARS-CoV-2 Omicron Sequences Carrying P681R Mutation, New York, USA.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  317. SONG JS, Lee J, Kim M, Jeong HS, et al
    Serial Intervals and Household Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  318. DAVIDO B, Jaffal K, Annane D, Lawrence C, et al
    Predictors of Nonseroconversion after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2022;28:492-493.
    PubMed    


  319. LEE H, Sung HK, Lee D, Choi Y, et al
    Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea.
    Emerg Infect Dis. 2022;28:347-353.
    PubMed     Abstract available


  320. HEGDE ST, Bhuiyan TR, Akhtar M, Islam T, et al
    High Infection Attack Rate after SARS-CoV-2 Delta Surge, Chattogram, Bangladesh.
    Emerg Infect Dis. 2022;28:491-492.
    PubMed    


  321. KRIEGER E, Kudryavtsev A, Sharashova E, Postoev V, et al
    Seroprevalence of SARS-Cov-2 Antibodies in Adults, Arkhangelsk, Russia.
    Emerg Infect Dis. 2022;28:463-465.
    PubMed     Abstract available


  322. PARK AK, Kim IH, Man Kim H, Lee H, et al
    SARS-CoV-2 B.1.619 and B.1.620 Lineages, South Korea, 2021.
    Emerg Infect Dis. 2022;28:415-419.
    PubMed     Abstract available


  323. MANNING J, Zaidi I, Lon C, Rosas LA, et al
    SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia.
    Emerg Infect Dis. 2022;28:440-444.
    PubMed     Abstract available


  324. BHUIYAN TR, Hulse JD, Hegde ST, Akhtar M, et al
    SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March-June 2021.
    Emerg Infect Dis. 2022;28:429-431.
    PubMed     Abstract available


  325. MIOT EF, Worthington BM, Ng KH, de Lataillade LG, et al
    Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong.
    Emerg Infect Dis. 2022;28:467-470.
    PubMed     Abstract available


  326. CHANH HQ, Trieu HT, Vuong HNT, Hung TK, et al
    Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam.
    Emerg Infect Dis. 2022;28:282-290.
    PubMed     Abstract available


  327. PIRET J, Boivin G
    Viral Interference between Respiratory Viruses.
    Emerg Infect Dis. 2022;28:273-281.
    PubMed     Abstract available


    January 2022
  328. DE SANTIS GC, Oliveira LC, Garibaldi PMM, Almado CEL, et al
    High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  329. GIULIANO AR, Pilon-Thomas S, Schell MJ, Abrahamsen M, et al
    SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, October 2020-March 2021.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  330. CHAN MC
    Return of Norovirus and Rotavirus Activity in Winter 202021 in City with Strict COVID-19 Control Strategy, Hong Kong, China.
    Emerg Infect Dis. 2022;28.
    PubMed     Abstract available


  331. GU H, Cheng SSM, Krishnan P, Ng DYM, et al
    Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2.
    Emerg Infect Dis. 2022;28:247-250.
    PubMed     Abstract available


  332. SUTHAR AB, Schubert S, Garon J, Couture A, et al
    Coronavirus Disease Case Definitions, Diagnostic Testing Criteria, and Surveillance in 25 Countries with Highest Reported Case Counts.
    Emerg Infect Dis. 2022;28:148-156.
    PubMed     Abstract available


  333. COOKSEY GLS, Morales C, Linde L, Schildhauer S, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021.
    Emerg Infect Dis. 2022;28:9-19.
    PubMed     Abstract available


  334. CHIU SS, Cowling BJ, Peiris JSM, Chan ELY, et al
    Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong.
    Emerg Infect Dis. 2022;28:62-68.
    PubMed     Abstract available


    December 2021
  335. FOX-LEWIS A, Williamson F, Harrower J, Ren X, et al
    Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa).
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  336. NICOLETE VC, Rodrigues PT, Fernandes ARJ, Corder RM, et al
    Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  337. KERTES J, Gez SB, Saciuk Y, Supino-Rosin L, et al
    Effectiveness of mRNA BNT162b2 Vaccine 6 Months after Vaccination among Patients in Large Health Maintenance Organization, Israel.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  338. GRAYO S, Troupin C, Diagne MM, Sagno H, et al
    SARS-CoV-2 Circulation, Guinea, March 2020-July 2021.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  339. RYU S, Kim D, Lim JS, Ali ST, et al
    Serial Interval and Transmission Dynamics during SARS-CoV-2 Delta Variant Predominance, South Korea.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  340. KISLAYA I, Rodrigues EF, Borges V, Gomes JP, et al
    Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  341. GU H, Krishnan P, Ng DYM, Chang LDJ, et al
    Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  342. LI A, Moore K, Bowthorpe L, Sousa J, et al
    Limited Propagation of SARS-CoV-2 among Children in a Childcare Center, Canada, 2021.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  343. CHEA N, Brown CJ, Eure T, Ramirez RA, et al
    Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May-December 2020.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  344. HERNANDEZ-AVILA M, Tamayo-Ortiz M, Vieyra-Romero W, Gutierrez-Diaz H, et al
    Use of Private Sector Workforce Respiratory Disease Short-Term Disability Claims to Assess SARS-CoV-2, Mexico, 2020.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  345. CHANG YS, Mayer S, Davis ES, Figueroa E, et al
    Transmission Dynamics of Large Coronavirus Disease Outbreak in Homeless Shelter, Chicago, Illinois, USA, 2020.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  346. DA SILVA JF, Esteves RJ, Siza C, Soares EP, et al
    Cluster of SARS-CoV-2 Gamma Variant Infections, Parintins, Brazil, March 2021.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  347. MITCHELL PK, Martins M, Reilly T, Caserta LC, et al
    SARS-CoV-2 B.1.1.7 Variant Infection in Malayan Tigers, Virginia, USA.
    Emerg Infect Dis. 2021;27:3171-3173.
    PubMed     Abstract available


  348. JEON HJ, Marks F, Sugimoto J, Im J, et al
    Surge of Typhoid Intestinal Perforations as Possible Result of COVID-19-Associated Delays in Seeking Care, Madagascar.
    Emerg Infect Dis. 2021;27:3163-3165.
    PubMed     Abstract available


  349. VAN DOREMALEN N, Letko M, Fischer RJ, Bushmaker T, et al
    SurfaceAerosol Stability and Pathogenicity of Diverse Middle East Respiratory Syndrome Coronavirus Strains, 20122018.
    Emerg Infect Dis. 2021;27:3052-3062.
    PubMed     Abstract available


  350. POLONSKY JA, Bohning D, Keita M, Ahuka-Mundeke S, et al
    Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020.
    Emerg Infect Dis. 2021;27:3063-3072.
    PubMed     Abstract available


  351. CHOI YK, Moon JY, Kim J, Yoo IS, et al
    Postvaccination Multisystem Inflammatory Syndrome in Adult with No Evidence of Prior SARS-CoV-2 Infection.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


    November 2021
  352. RODRIGUEZ-GRANDE C, Alcala L, Estevez A, Sola-Campoy PJ, et al
    Systematic Genomic and Clinical Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections and Recurrences Involving the Same Strain.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  353. SOMEKH I, Simoes EAF, Somekh E
    Coronavirus Disease Spread during Summer Vacation, Israel, 2020.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  354. YADOULETON A, Sander AL, Adewumi P, de Oliveira Filho EF, et al
    Emergence of SARS-CoV-2 Delta Variant, Benin, May-July 2021.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  355. GHARPURE R, Sami S, Vostok J, Johnson H, et al
    Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  356. PETERSEN MS, Strom M, Fjallsbak JP, Hansen JL, et al
    Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  357. HEINRICH F, Schroder AS, Gerberding AL, Gerling M, et al
    Postmortem Antigen-Detecting Rapid Diagnostic Tests to Predict Infectivity of SARS-CoV-2-Associated Deaths.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  358. CHALKER VJ, Adler H, Ball R, Naik F, et al
    Fatal Co-infections with SARS-CoV-2 and Legionella pneumophila, England.
    Emerg Infect Dis. 2021;27:2950-2952.
    PubMed     Abstract available


  359. BIGOUETTE JP, Ford L, Segaloff HE, Langolf K, et al
    Association of Shared Living Spaces and COVID-19 in University Students, Wisconsin, USA, 2020.
    Emerg Infect Dis. 2021;27:2882-2886.
    PubMed     Abstract available


    October 2021
  360. KANT R, Nguyen PT, Blomqvist S, Erdin M, et al
    Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  361. BUGEMBE DL, Phan MVT, Abias AG, Ayei J, et al
    SARS-CoV-2 Variants, South Sudan, January-March 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  362. JOHNSON KE, Woody S, Lachmann M, Fox SJ, et al
    Real-time Projections of SARS-CoV-2 B.1.1.7 Variant in a University Setting, Texas, USA.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  363. SHOBAYO B, Mishra M, Sameroff S, Petrosov A, et al
    SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  364. FIELDS VL, Kracalik IT, Carthel C, Lopez A, et al
    Coronavirus Disease Contact Tracing Outcomes and Cost, Salt Lake County, Utah, USA, March-May 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  365. STICH M, Elling R, Renk H, Janda A, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Households with Children, Southwest Germany, May-August 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  366. SCHULZ C, Martina B, Mirolo M, Muller E, et al
    SARS-CoV-2-Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  367. SHAO SC, Wang CH, Chang KC, Hung MJ, et al
    Guillain-Barre Syndrome Associated with COVID-19 Vaccination.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  368. PURPURA LJ, Alukal J, Chong AM, Liu L, et al
    SARS-CoV-2 Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  369. YANG B, Sullivan SG, Du Z, Tsang TK, et al
    Effectiveness of International Travel Controls for Delaying Local Outbreaks of COVID-19.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  370. RILEY J, Huntley JM, Miller JA, Slaichert ALB, et al
    Mask Effectiveness for Preventing Secondary Cases of COVID-19, Johnson County, Iowa, USA.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  371. SAITO T, Muto K, Tanaka M, Okabe N, et al
    Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February-June 2020.
    Emerg Infect Dis. 2021;27:1-9.
    PubMed     Abstract available


  372. MISHRA A, Kumar N, Bhatia S, Aasdev A, et al
    SARS-CoV-2 Delta Variant among Asiatic Lions, India.
    Emerg Infect Dis. 2021;27:2723-2725.
    PubMed     Abstract available


  373. SKIDMORE PT, Kaelin EA, Holland LA, Maqsood R, et al
    Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA.
    Emerg Infect Dis. 2021;27:2718-2720.
    PubMed     Abstract available


  374. MCCORMICK DW, Kugeler KJ, Marx GE, Jayanthi P, et al
    Effects of COVID-19 Pandemic on Reported Lyme Disease, United States, 2020.
    Emerg Infect Dis. 2021;27:2715-2717.
    PubMed     Abstract available


  375. GU H, Chu DKW, Chang LDJ, Cheuk SSY, et al
    Genetic Diversity of SARS-CoV-2 among Travelers Arriving in Hong Kong.
    Emerg Infect Dis. 2021;27:2666-2668.
    PubMed     Abstract available


  376. PARKER JJ, Octaria R, Smith MD, Chao SJ, et al
    Characteristics, Comorbidities, and Data Gaps for Coronavirus Disease Deaths, Tennessee, USA.
    Emerg Infect Dis. 2021;27:2521-2528.
    PubMed     Abstract available


  377. PARKER DM, Bruckner T, Vieira VM, Medina C, et al
    Predictors of Test Positivity, Mortality, and Seropositivity during the Early Coronavirus Disease Epidemic, Orange County, California, USA.
    Emerg Infect Dis. 2021;27:2604-2618.
    PubMed     Abstract available


    September 2021
  378. NGUYEN KH, Yankey D, Coy KC, Brookmeyer KA, et al
    COVID-19 Vaccination Coverage, Intent, Knowledge, Attitudes, and Beliefs among Essential Workers, United States.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  379. GROME HN, Threlkeld M, Threlkeld S, Newman C, et al
    Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  380. CURRIE DW, Moreno GK, Delahoy MJ, Pray IW, et al
    Interventions to Disrupt Coronavirus Disease Transmission at a University, Wisconsin, USA, August-October 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  381. RIZZO KR, Hoover C, Jain S, Sun M, et al
    Influenza and SARS-CoV-2 Coinfections in California, USA, September 2020-April 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  382. ARORA S, Hemmige VS, Mandke C, Chansoria M, et al
    Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  383. JOSHI S, Telang R, Tambe M, Havaldar R, et al
    Outbreak of Mucormycosis in Coronavirus Disease Patients, Pune, India.
    Emerg Infect Dis. 2021;28.
    PubMed     Abstract available


  384. GLATMAN-FREEDMAN A, Hershkovitz Y, Kaufman Z, Dichtiar R, et al
    Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  385. VALKENBURG SA, Cheng SMS, Hachim A, Peiris M, et al
    Postmortem Stability of SARS-CoV-2 in Mouse Lung Tissue.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  386. HUNSAWONG T, Fernandez S, Buathong R, Khadthasrima N, et al
    Limited Protection of Inactivated SARS-CoV-2 Vaccine against Wuhan Strain and Variants of Concern.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  387. ADAMOSKI D, de Oliveira JC, Bonatto AC, Wassem R, et al
    Large-Scale Screening of Asymptomatic Persons for SARS-CoV-2 Variants of Concern and Gamma Takeover, Brazil.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  388. JANSSEN NAF, Nyga R, Vanderbeke L, Jacobs C, et al
    Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis(1).
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  389. BAJ A, Novazzi F, Pasciuta R, Genoni A, et al
    Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  390. KLEYNHANS J, Tempia S, Wolter N, von Gottberg A, et al
    SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  391. RACNIK J, Kocevar A, Slavec B, Korva M, et al
    Transmission of SARS-CoV-2 from Human to Domestic Ferret.
    Emerg Infect Dis. 2021;27:2450-2453.
    PubMed     Abstract available


  392. MURPHY M, Dhrolia I, Zanowick-Marr A, Tao J, et al
    A Community-Adapted Approach to SARS-CoV-2 Testing for Medically Underserved Populations, Rhode Island, USA.
    Emerg Infect Dis. 2021;27:2445-2449.
    PubMed     Abstract available


  393. DOUGLAS J, Geoghegan JL, Hadfield J, Bouckaert R, et al
    Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand.
    Emerg Infect Dis. 2021;27:2361-2368.
    PubMed     Abstract available


  394. MCCLARY-GUTIERREZ JS, Mattioli MC, Marcenac P, Silverman AI, et al
    SARS-CoV-2 Wastewater Surveillance for Public Health Action.
    Emerg Infect Dis. 2021;27:1-8.
    PubMed     Abstract available


  395. LI Y, Liu J, Yang Z, Yu J, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 to Close Contacts, China, January-February 2020.
    Emerg Infect Dis. 2021;27:2288-2293.
    PubMed     Abstract available


  396. RABALSKI L, Kosinski M, Smura T, Aaltonen K, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 in Farmed Mink (Neovison vison), Poland.
    Emerg Infect Dis. 2021;27:2333-2339.
    PubMed     Abstract available


  397. HOLLOWAY P, Gibson M, van Doremalen N, Nash S, et al
    Risk Factors for Middle East Respiratory Syndrome Coronavirus Infection among Camel Populations, Southern Jordan, 2014-2018.
    Emerg Infect Dis. 2021;27:2301-2311.
    PubMed     Abstract available


  398. MAEDA H, Sando E, Toizumi M, Arima Y, et al
    Epidemiology of Coronavirus Disease Outbreak among Crewmembers on Cruise Ship, Nagasaki City, Japan, April 2020.
    Emerg Infect Dis. 2021;27:2251-2260.
    PubMed     Abstract available


  399. ALLAM C, Gaymard A, Descours G, Ginevra C, et al
    Co-infection with Legionella and SARS-CoV-2, France, March 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  400. SURASI K, Cummings KJ, Hanson C, Morris MK, et al
    Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  401. CHUNG GKK, Chan SM, Chan YH, Woo J, et al
    Socioeconomic Patterns of COVID-19 Clusters in Low-Incidence City, Hong Kong.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  402. SAMORE MH, Looney A, Orleans B, Greene T, et al
    Probability-Based Estimates of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Detection Fraction, Utah, USA.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


    August 2021
  403. BROOKS YM, Gryskwicz B, Sheehan S, Piers S, et al
    Detection of SARS-CoV-2 in Wastewater at Residential College, Maine, USA, August-November 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  404. SANDER AL, Yadouleton A, de Oliveira Filho EF, Tchibozo C, et al
    Mutations Associated with SARS-CoV-2 Variants of Concern, Benin, Early 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  405. CHOI GJ, Baek SH, Kim J, Kim JH, et al
    Fatal Systemic Capillary Leak Syndrome after SARS-COV-2Vaccination in Patient with Multiple Myeloma.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  406. REGO N, Costabile A, Paz M, Salazar C, et al
    Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  407. CANTO E CASTRO L, Pereira AHG, Ribeiro R, Alves C, et al
    Prevalence of SARS-CoV-2 Antibodies after First 6 Months of COVID-19 Pandemic, Portugal.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  408. PETERSEN MS, Kristiansen MF, Reinert HW, Fjallsbak JP, et al
    Seroprevalence of SARS-CoV-2-Specific Antibodies among Quarantined Close Contacts of COVID-19 Patients, Faroe Islands, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  409. KIM HY, Oh IH, Lee J, Seon JY, et al
    Policy Review and Modeling Analysis of Mitigation Measures for Coronavirus Disease Epidemic Control, Health System, and Disease Burden, South Korea.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  410. IMMERGLUCK K, Gonzalez MD, Frediani JK, Levy JM, et al
    Correlation of SARS-CoV-2 Subgenomic RNA with Antigen Detection in Nasal Midturbinate Swab Specimens.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  411. TINKER SC, Szablewski CM, Litvintseva AP, Drenzek C, et al
    Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  412. WANG Y, Siesel C, Chen Y, Lopman B, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Georgia, USA, February 1-July 13, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  413. HOGAN CA, Jassem AN, Sbihi H, Joffres Y, et al
    Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  414. MAISON-FOMOTAR M, Sivasubramanian G
    Bordetella hinzii Pneumonia and Bacteremia in a Patient with SARS-CoV-2 Infection.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  415. UJIIE M, Tsuzuki S, Nakamoto T, Iwamoto N, et al
    Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  416. TRUFFOT A, Andreani J, Le Marechal M, Caporossi A, et al
    SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  417. BADR DA, Picone O, Bevilacqua E, Carlin A, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 and Pregnancy Outcomes According to Gestational Age at Time of Infection.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  418. SHUKLA BS, Warde PR, Knott E, Arenas S, et al
    Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  419. LOUIE JK, Agraz-Lara R, Romo L, Crespin F, et al
    Tuberculosis-Associated Hospitalizations and Deaths after COVID-19 Shelter-In-Place, San Francisco, California, USA.
    Emerg Infect Dis. 2021;27:2227-2229.
    PubMed     Abstract available


  420. LEONG LEX, Soubrier J, Turra M, Denehy E, et al
    Whole-Genome Sequencing of SARS-CoV-2 from Quarantine Hotel Outbreak.
    Emerg Infect Dis. 2021;27:2219-2221.
    PubMed     Abstract available


  421. HOROWITZ HW, Behar C, Greene J
    COVID-19 and the Consequences of Anchoring Bias.
    Emerg Infect Dis. 2021;27:2235-2236.
    PubMed     Abstract available


  422. HINES JZ, Fwoloshi S, Kampamba D, Barradas DT, et al
    SARS-CoV-2 Prevalence among Outpatients during Community Transmission, Zambia, July 2020.
    Emerg Infect Dis. 2021;27:2166-2168.
    PubMed     Abstract available


  423. RICE WM, Chudasama DY, Lewis J, Senyah F, et al
    Epidemiology of COVID-19 in Prisons, England, 2020.
    Emerg Infect Dis. 2021;27:2183-2186.
    PubMed     Abstract available


  424. BOSCO-LAUTH AM, Root JJ, Porter SM, Walker AE, et al
    Peridomestic Mammal Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Emerg Infect Dis. 2021;27:2073-2080.
    PubMed     Abstract available


  425. ABATAN B, Agboghoroma O, Akemoke F, Antonio M, et al
    Intense and Mild First Epidemic Wave of Coronavirus Disease, The Gambia.
    Emerg Infect Dis. 2021;27:2064-2072.
    PubMed     Abstract available


    July 2021
  426. MONGE S, Olmedo C, Alejos B, Lapena MF, et al
    Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  427. CHEUNG PC, Eisch AR, Maleque N, Polly DM, et al
    Fatal Exacerbations of Systemic Capillary Leak Syndrome Complicating Coronavirus Disease.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  428. FOCOSI D, Novazzi F, Genoni A, Dentali F, et al
    Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  429. HOFFMAN SA, Costales C, Sahoo MK, Palanisamy S, et al
    SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  430. VIGNIER N, Berot V, Bonnave N, Peugny S, et al
    Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  431. ECKSTEIN S, Ehmann R, Gritli A, Ben Yahia H, et al
    Prevalence of Middle East Respiratory Syndrome Coronavirus in Dromedary Camels, Tunisia.
    Emerg Infect Dis. 2021;27:1964-1968.
    PubMed     Abstract available


  432. GORTAZAR C, Barroso-Arevalo S, Ferreras-Colino E, Isla J, et al
    Natural SARS-CoV-2 Infection in Kept Ferrets, Spain.
    Emerg Infect Dis. 2021;27:1994-1996.
    PubMed     Abstract available


  433. SCHULZ C, Wylezich C, Wernike K, Grundl M, et al
    Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home.
    Emerg Infect Dis. 2021;27:1974-1976.
    PubMed     Abstract available


  434. VAN LOON W, Rossig H, Burock S, Hofmann J, et al
    Emergence of SARS-CoV-2 B.1.1.7 Lineage at Outpatient Testing Site, Berlin, Germany, January-March 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  435. ZHANG C, Guo Z, Zhao Z, Wang T, et al
    SARS-CoV-2 Aerosol Exhaled by Experimentally Infected Cynomolgus Monkeys.
    Emerg Infect Dis. 2021;27:1979-1981.
    PubMed     Abstract available


  436. WANG X, Du Z, Johnson KE, Pasco RF, et al
    Effects of COVID-19 Vaccination Timing and Risk Prioritization on Mortality Rates, United States.
    Emerg Infect Dis. 2021;27:1976-1979.
    PubMed     Abstract available


  437. SOKO RN, Burke RM, Feasey HRA, Sibande W, et al
    Effects of Coronavirus Disease Pandemic on Tuberculosis Notifications, Malawi.
    Emerg Infect Dis. 2021;27:1831-1839.
    PubMed     Abstract available


  438. LIAO Q, Dong M, Yuan J, Fielding R, et al
    Assessing Community Vulnerability over 3 Waves of COVID-19 Pandemic, Hong Kong, China.
    Emerg Infect Dis. 2021;27:1935-1939.
    PubMed     Abstract available


  439. GULTOM M, Licheri M, Laloli L, Wider M, et al
    Susceptibility of Well-Differentiated Airway Epithelial Cell Cultures from Domestic and Wild Animals to Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2021;27:1811-1820.
    PubMed     Abstract available


  440. KWOK KO, Li KK, Tang A, Tsoi MTF, et al
    Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong.
    Emerg Infect Dis. 2021;27:1802-1810.
    PubMed     Abstract available


  441. AMIRTHALINGAM G, Whitaker H, Brooks T, Brown K, et al
    Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.
    Emerg Infect Dis. 2021;27:1795-1801.
    PubMed     Abstract available


  442. BROWN A, Schwarcz L, Counts CR, Barnard LM, et al
    Risk for Acquiring COVID-19 Illness among Emergency Medical Service Personnel Exposed to Aerosol-Generating Procedures.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


    June 2021
  443. LIU W, Russell RM, Bibollet-Ruche F, Skelly AN, et al
    Predictors of Nonseroconversion after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  444. OTIENO NA, Azziz-Baumgartner E, Nyawanda BO, Oreri E, et al
    SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  445. BURKE RM, Calderwood L, Killerby ME, Ashworth CE, et al
    Patterns of Virus Exposure and Presumed Household Transmission among Persons with Coronavirus Disease, United States, January-April 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  446. MARR LC
    SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021.
    Emerg Infect Dis. 2021;27.
    PubMed    


  447. SUBBARAO S, Campbell H, Ribeiro S, Clark SA, et al
    Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  448. BUCHWALD AG, Bayham J, Adams J, Bortz D, et al
    Estimating the Impact of Statewide Policies to Reduce Spread of Severe Acute Respiratory Syndrome Coronavirus 2 in Real Time, Colorado, USA.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  449. LYNCH M, Macori G, Fanning S, O'Regan E, et al
    Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  450. LEHNERTZ NB, Wang X, Garfin J, Taylor J, et al
    Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 in High-Density Settings, Minnesota, USA, March-June 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  451. WILLIAMS V, Edem B, Calnan M, Otwombe K, et al
    Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  452. TOBER-LAU P, Schwarz T, Hillus D, Spieckermann J, et al
    Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February-March 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  453. SCHWARZ T, Tober-Lau P, Hillus D, Helbig ET, et al
    Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  454. GONCALVES MR, Dos Reis RCP, Tolio RP, Pellanda LC, et al
    Social Distancing, Mask Use, and Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Brazil, April-June 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  455. PATEL A, Agarwal R, Rudramurthy SM, Shevkani M, et al
    Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  456. HOCH M, Vogel S, Kolberg L, Dick E, et al
    Weekly SARS-CoV-2 Sentinel Surveillance in Primary Schools, Kindergartens, and Nurseries, Germany, JuneNovember 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  457. WIENS KE, Mawien PN, Rumunu J, Slater D, et al
    Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020(1).
    Emerg Infect Dis. 2021;27:1598-1606.
    PubMed     Abstract available


  458. DE COCK KM, Jaffe HW, Curran JW
    Reflections on 40 Years of AIDS.
    Emerg Infect Dis. 2021;27:1553-1560.
    PubMed     Abstract available


    May 2021
  459. SALZMAN MB, Huang CW, O'Brien CM, Castillo RD, et al
    Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  460. TOH ZQ, Higgins RA, Do LAH, Rautenbacher K, et al
    Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  461. CHU DKW, Gu H, Chang LDJ, Cheuk SSY, et al
    SARS-CoV-2 Superspread in Fitness Center, Hong Kong, China, March 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  462. DECARO N, Vaccari G, Lorusso A, Lorusso E, et al
    Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  463. HATZIANASTASIOU S, Mouchtouri VA, Pavli A, Tseroni M, et al
    COVID-19 Outbreak on a Passenger Ship and Assessment of Response Measures, Greece, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  464. CONTRERAS Z, Ngo V, Pulido M, Washburn F, et al
    Industry Sectors Highly Affected by Worksite Outbreaks of Coronavirus Disease, Los Angeles County, California, USA, March 19-September 30, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  465. COLITTI B, Bertolotti L, Mannelli A, Ferrara G, et al
    Cross-Sectional Serosurvey of Companion Animals Housed with SARS-CoV-2-Infected Owners, Italy.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  466. ALSHUKAIRI AN, Zhao J, Al-Mozaini MA, Wang Y, et al
    Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  467. FOURATI S, Decousser JW, Khouider S, N'Debi M, et al
    Novel SARS-CoV-2 Variant Derived from Clade 19B, France.
    Emerg Infect Dis. 2021;27:1540-1543.
    PubMed     Abstract available


  468. CHU DKW, Hui KPY, Gu H, Ko RLW, et al
    Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China.
    Emerg Infect Dis. 2021;27:1492-1495.
    PubMed     Abstract available


  469. REED IG, Walker ES, Landguth EL
    SARS-CoV-2 Serial Interval Variation, Montana, USA, March 1-July 31, 2020.
    Emerg Infect Dis. 2021;27:1486-1491.
    PubMed     Abstract available


  470. VERHASSELT HL, Buer J, Dedy J, Ziegler R, et al
    COVID-19 Co-infection with Legionella pneumophila in 2 Tertiary-Care Hospitals, Germany.
    Emerg Infect Dis. 2021;27:1535-1537.
    PubMed     Abstract available


  471. ZHAO S, Schuurman N, Li W, Wang C, et al
    Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands.
    Emerg Infect Dis. 2021;27:1362-1370.
    PubMed     Abstract available


  472. GREENE SK, Peterson ER, Balan D, Jones L, et al
    Detecting COVID-19 Clusters at High Spatiotemporal Resolution, New York City, New York, USA, June-July 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  473. MEREDITH HR, Arehart E, Grantz KH, Beams A, et al
    Coordinated Strategy for a Model-Based Decision Support Tool for Coronavirus Disease, Utah, USA.
    Emerg Infect Dis. 2021;27:1259-1265.
    PubMed     Abstract available


  474. IZQUIERDO-LARA R, Elsinga G, Heijnen L, Munnink BBO, et al
    Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium.
    Emerg Infect Dis. 2021;27:1405-1415.
    PubMed     Abstract available


  475. BROWN AE, Heinsbroek E, Kall MM, Allen H, et al
    Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March-December 2020.
    Emerg Infect Dis. 2021;27:1468-1471.
    PubMed     Abstract available


  476. GEOGHEGAN JL, Douglas J, Ren X, Storey M, et al
    Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand.
    Emerg Infect Dis. 2021;27:1317-1322.
    PubMed     Abstract available


  477. JEREMIJENKO A, Chemaitelly H, Ayoub HH, Alishaq M, et al
    Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
    Emerg Infect Dis. 2021;27:1343-1352.
    PubMed     Abstract available


  478. EHRLICH HY, Harizaj A, Campbell L, Colt M, et al
    SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA.
    Emerg Infect Dis. 2021;27:1288-1295.
    PubMed     Abstract available


  479. CODREANU TA, Ngeh S, Trewin A, Armstrong PK, et al
    Successful Control of an Onboard COVID-19 Outbreak Using the Cruise Ship as a Quarantine Facility, Western Australia, Australia.
    Emerg Infect Dis. 2021;27:1279-1287.
    PubMed     Abstract available


  480. ORTIZ N, Villarino E, Lee JT, Bajema KL, et al
    Epidemiologic Findings from Case Investigations and Contact Tracing for First 200 Cases of Coronavirus Disease, Santa Clara County, California, USA.
    Emerg Infect Dis. 2021;27:1301-1308.
    PubMed     Abstract available


  481. WIEGELE PN, Kabar I, Kerschke L, Froemmel C, et al
    Symptom Diary-Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020.
    Emerg Infect Dis. 2021;27:1353-1361.
    PubMed     Abstract available


  482. WANG L, Fan X, Bonenfant G, Cui D, et al
    Susceptibility to SARS-CoV-2 of Cell Lines and Substrates Commonly Used to Diagnose and Isolate Influenza and Other Viruses.
    Emerg Infect Dis. 2021;27:1380-1392.
    PubMed     Abstract available


    April 2021
  483. RESENDE PC, Bezerra JF, Teixeira Vasconcelos RH, Arantes I, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June-October 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  484. AMORIM MR, Souza WM, Barros ACG Jr, Toledo-Teixeira DA, et al
    Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  485. ZACHARIAS M, Stangl V, Thuringer A, Loibner M, et al
    Rapid Antigen Test for Postmortem Evaluation of SARS-CoV-2 Carriage.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  486. YOUSAF Z, Mushtaq K
    Postvaccination COVID-19 among Healthcare Workers, Israel.
    Emerg Infect Dis. 2021;27.
    PubMed    


  487. YAMADA Y, Fujinami K, Eguchi T, Takefuji H, et al
    Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  488. KATELARIS AL, Wells J, Clark P, Norton S, et al
    Epidemiologic Evidence for Airborne Transmission of SARS-CoV-2 during Church Singing, Australia, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  489. FINTELMAN-RODRIGUES N, da Silva APD, Dos Santos MC, Saraiva FB, et al
    Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  490. GHAI RR, Carpenter A, Liew AY, Martin KB, et al
    Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses.
    Emerg Infect Dis. 2021;27:1015-1022.
    PubMed     Abstract available


  491. WATKINS AE, Fenichel EP, Weinberger DM, Vogels CBF, et al
    Increased SARS-CoV-2 Testing Capacity with Pooled Saliva Samples.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  492. KRAAY ANM, Hayashi MAL, Berendes DM, Sobolik JS, et al
    Risk for Fomite-Mediated Transmission of SARS-CoV-2 in Child Daycares, Schools, Nursing Homes, and Offices.
    Emerg Infect Dis. 2021;27:1229-1231.
    PubMed     Abstract available


  493. OTT IM, Strine MS, Watkins AE, Boot M, et al
    Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva.
    Emerg Infect Dis. 2021;27:1146-1150.
    PubMed     Abstract available


  494. ULRICH L, Michelitsch A, Halwe N, Wernike K, et al
    Experimental SARS-CoV-2 Infection of Bank Voles.
    Emerg Infect Dis. 2021;27:1193-1195.
    PubMed     Abstract available


    March 2021
  495. MATIC N, Lowe CF, Ritchie G, Stefanovic A, et al
    Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, in British Columbia, Canada.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  496. HAIM-BOUKOBZA S, Roquebert B, Trombert-Paolantoni S, Lecorche E, et al
    Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26-February 16, 2021.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  497. DU Z, Wang L, Yang B, Ali ST, et al
    Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  498. RABAGLIATI R, Rodriguez N, Nunez C, Huete A, et al
    COVID-19-Associated Mold Infection in Critically Ill Patients, Chile.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  499. NINO-TARAVILLA C, Otaola-Arca H, Lara-Aguilera N, Zuleta-Morales Y, et al
    Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  500. HEANEY AK, Head JR, Broen K, Click K, et al
    Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  501. SHROTRI M, Harris RJ, Rodger A, Planche T, et al
    Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
    Emerg Infect Dis. 2021;27:1155-1158.
    PubMed     Abstract available


  502. EICHLER N, Thornley C, Swadi T, Devine T, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa).
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  503. IGLI Z, Velzing J, van Beek J, van de Vijver D, et al
    Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  504. WILSON TM, Paddock CD, Reagan-Steiner S, Bhatnagar J, et al
    Intersecting Paths of Emerging and Reemerging Infectious Diseases.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  505. LEWNARD JA, Mora AM, Nkwocha O, Kogut K, et al
    Prevalence and Clinical Profile of Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Farmworkers, California, June-November 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  506. CUEVAS LE, Santos VS, Lima SVMA, Kontogianni K, et al
    Systematic Review of Pooling Sputum as an Efficient Method for Xpert MTB/RIF Tuberculosis Testing during the COVID-19 Pandemic.
    Emerg Infect Dis. 2021;27:719-727.
    PubMed     Abstract available


  507. AKINBAMI LJ, Chan PA, Vuong N, Sami S, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity among Healthcare Personnel in Hospitals and Nursing Homes, Rhode Island, USA, July-August 2020.
    Emerg Infect Dis. 2021;27:823-834.
    PubMed     Abstract available


  508. MIYAHARA R, Tsuchiya N, Yasuda I, Ko YK, et al
    Familial Clusters of Coronavirus Disease in 10 Prefectures, Japan, February-May 2020.
    Emerg Infect Dis. 2021;27:915-918.
    PubMed     Abstract available


  509. KAWASHIMA T, Nomura S, Tanoue Y, Yoneoka D, et al
    Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January-May 2020(1).
    Emerg Infect Dis. 2021;27:789-795.
    PubMed     Abstract available


  510. SHRINER SA, Ellis JW, Root JJ, Roug A, et al
    SARS-CoV-2 Exposure in Escaped Mink, Utah, USA.
    Emerg Infect Dis. 2021;27:988-990.
    PubMed     Abstract available


  511. PHUONG HVM, Tung TS, Trang UTH, Hang NLK, et al
    Novel Mutation of SARS-CoV-2, Vietnam, July 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


    February 2021
  512. NONAKA CKV, Franco MM, Graf T, de Lorenzo Barcia CA, et al
    Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  513. BULLOCK HA, Goldsmith CS, Zaki SR, Martines RB, et al
    Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  514. BENDER JK, Brandl M, Hohle M, Buchholz U, et al
    Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  515. FONG MW, Leung NHL, Cowling BJ, Wu P, et al
    Upper Respiratory Infections in Schools and Childcare Centers Reopening after COVID-19 Dismissals, Hong Kong.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  516. HERSTEIN JJ, Degarege A, Stover D, Austin C, et al
    Characteristics of SARS-CoV-2 Transmission among Meat Processing Workers in Nebraska, USA, and Effectiveness of Risk Mitigation Measures.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  517. FUJINO T, Nomoto H, Kutsuna S, Ujiie M, et al
    Novel SARS-CoV-2 Variant Identified in Travelers from Brazil to Japan.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  518. MAGGI F, Novazzi F, Genoni A, Baj A, et al
    Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  519. PATEL A, Emerick M, Cabunoc MK, Williams MH, et al
    Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  520. SALMANTON-GARCIA J, Sprute R, Stemler J, Bartoletti M, et al
    COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  521. CHOE YJ, Choi EH, Choi JW, Eun BW, et al
    Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  522. LETIZIA AG, Ge Y, Goforth CW, Weir DL, et al
    SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  523. CAROSELLA LM, Pryluka D, Maranzana A, Barcan L, et al
    Characteristics of Patients Co-infected with Severe Acute Respiratory Syndrome Coronavirus 2 and Dengue Virus, Buenos Aires, Argentina, March-June 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  524. CHIBA S, Halfmann PJ, Hatta M, Maemura T, et al
    Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection.
    Emerg Infect Dis. 2021;27:660-663.
    PubMed     Abstract available


  525. SAMI S, Vuong N, Miller H, Priestley R, et al
    SARS-CoV-2 Infection and Mitigation Efforts among Office Workers, Washington, DC, USA.
    Emerg Infect Dis. 2021;27:669-672.
    PubMed     Abstract available


  526. MAI HK, Trieu NB, Long TH, Thanh HT, et al
    Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
    Emerg Infect Dis. 2021;27:663-666.
    PubMed     Abstract available


  527. KAR SS, Sarkar S, Murali S, Dhodapkar R, et al
    Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020.
    Emerg Infect Dis. 2021;27:666-669.
    PubMed     Abstract available


  528. NG SH, Kaur P, Kremer C, Tan WS, et al
    Estimating Transmission Parameters for COVID-19 Clusters by Using Symptom Onset Data, Singapore, January-April 2020.
    Emerg Infect Dis. 2021;27:582-585.
    PubMed     Abstract available


  529. RADFORD AD, Singleton DA, Jewell C, Appleton C, et al
    Outbreak of Severe Vomiting in Dogs Associated with a Canine Enteric Coronavirus, United Kingdom.
    Emerg Infect Dis. 2021;27:517-528.
    PubMed     Abstract available


  530. YOSHIYAMA T, Saito Y, Masuda K, Nakanishi Y, et al
    Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.
    Emerg Infect Dis. 2021;27:628-631.
    PubMed     Abstract available


  531. HOGAN CA, Huang C, Sahoo MK, Wang H, et al
    Strand-Specific Reverse Transcription PCR for Detection of Replicating SARS-CoV-2.
    Emerg Infect Dis. 2021;27:632-635.
    PubMed     Abstract available


  532. GUIDRY JPD, Miller CA, Ksinan AJ, Rohan JM, et al
    COVID-19-Related Misinformation among Parents of Patients with Pediatric Cancer.
    Emerg Infect Dis. 2021;27:650-652.
    PubMed     Abstract available


  533. FRANCO D, Gonzalez C, Abrego LE, Carrera JP, et al
    Early Transmission Dynamics, Spread, and Genomic Characterization of SARS-CoV-2 in Panama.
    Emerg Infect Dis. 2021;27:612-615.
    PubMed     Abstract available


  534. VAHEY GM, Marshall KE, McDonald E, Martin SW, et al
    Symptom Profiles and Progression in Hospitalized and Nonhospitalized Patients with Coronavirus Disease, Colorado, USA, 2020.
    Emerg Infect Dis. 2021;27:385-395.
    PubMed     Abstract available


  535. SELVARAJU S, Kumar MS, Thangaraj JWV, Bhatnagar T, et al
    Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.
    Emerg Infect Dis. 2021;27:586-589.
    PubMed     Abstract available


  536. SYPSA V, Roussos S, Paraskevis D, Lytras T, et al
    Effects of Social Distancing Measures during the First Epidemic Wave of Severe Acute Respiratory Syndrome Infection, Greece.
    Emerg Infect Dis. 2021;27:452-462.
    PubMed     Abstract available


  537. AMIT S, Beni SA, Biber A, Grinberg A, et al
    Post-Vaccination COVID-19 among Healthcare Workers, Israel.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


    January 2021
  538. MEDLEY AM, Marston BJ, Toda M, Kobayashi M, et al
    Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February-April 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  539. KRISTIANSEN MF, Heimustovu BH, Borg SA, Mohr TH, et al
    Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  540. CLARO IM, da Silva Sales FC, Ramundo MS, Candido DS, et al
    Local Transmission of SARS-CoV-2 Lineage B.1.1.7, Brazil, December 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  541. DE VRIES M, Claassen L, Te Wierik MJM, van den Hof S, et al
    Dynamic Public Perceptions of the Coronavirus Disease Crisis, the Netherlands, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  542. SAMI S, Akinbami LJ, Petersen LR, Crawley A, et al
    Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  543. TSUKAMOTO T, Nakajima N, Sakurai A, Nakajima M, et al
    Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and Streptococcus pneumoniae.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  544. GOUVEA-REIS FA, Oliveira PD, Silva DCS, Borja LS, et al
    COVID-19 Outbreak in a Large Penitentiary Complex, April-June 2020, Brazil.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  545. SWADI T, Geoghegan JL, Devine T, McElnay C, et al
    Genomic Evidence of In-Flight Transmission of SARS-CoV-2 Despite Predeparture Testing.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  546. SCHEIER T, Schibli A, Eich G, Ruegg C, et al
    Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  547. VAN ASTEN L, Harmsen CN, Stoeldraijer L, Klinkenberg D, et al
    Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  548. WALLACE M, James AE, Silver R, Koh M, et al
    Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May-June, 2020.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  549. VRAGA EK, Bode L
    Addressing COVID-19 Misinformation on Social Media Preemptively and Responsively.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  550. HEINRICH F, Meissner K, Langenwalder F, Puschel K, et al
    Postmortem Stability of SARS-CoV-2 in Nasopharyngeal Mucosa.
    Emerg Infect Dis. 2021;27.
    PubMed     Abstract available


  551. LEUNG KS, Ng TT, Wu AK, Yau MC, et al
    Territorywide Study of Early Coronavirus Disease Outbreak, Hong Kong, China.
    Emerg Infect Dis. 2021;27:196-204.
    PubMed     Abstract available


  552. PICKERING BS, Smith G, Pinette MM, Embury-Hyatt C, et al
    Susceptibility of Domestic Swine to Experimental Infection with Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2021;27:104-112.
    PubMed     Abstract available


  553. LIN YT, Neumann J, Miller EF, Posner RG, et al
    Daily Forecasting of Regional Epidemics of Coronavirus Disease with Bayesian Uncertainty Quantification, United States.
    Emerg Infect Dis. 2021;27:767-778.
    PubMed     Abstract available


  554. MUNYUA PM, Ngere I, Hunsperger E, Kochi A, et al
    Low-Level Middle East Respiratory Syndrome Coronavirus among Camel Handlers, Kenya, 2019.
    Emerg Infect Dis. 2021;27:1201-1205.
    PubMed     Abstract available


  555. PETTRONE K, Burnett E, Link-Gelles R, Haight SC, et al
    Characteristics and Risk Factors of Hospitalized and Nonhospitalized COVID-19 Patients, Atlanta, Georgia, USA, March-April 2020.
    Emerg Infect Dis. 2021;27:1164-1168.
    PubMed     Abstract available


  556. HOLLIS ND, Li W, Van Dyke ME, Njie GJ, et al
    Racial and Ethnic Disparities in Incidence of SARS-CoV-2 Infection, 22 US States and DC, January 1-October 1, 2020.
    Emerg Infect Dis. 2021;27:1477-1481.
    PubMed     Abstract available


  557. ZHANG M, Zhou J, Jia S, Zhao X, et al
    Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China.
    Emerg Infect Dis. 2021;27:1543-1545.
    PubMed     Abstract available


  558. YUM S, Hong K, Sohn S, Kim J, et al
    Trends in Viral Respiratory Infections During COVID-19 Pandemic, South Korea.
    Emerg Infect Dis. 2021;27:1685-1688.
    PubMed     Abstract available


  559. SHU B, Kirby MK, Davis WG, Warnes C, et al
    Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2021;27:1821-1830.
    PubMed     Abstract available


  560. SMITH-JEFFCOAT SE, Koh M, Hoffman A, Rebolledo PA, et al
    Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing.
    Emerg Infect Dis. 2021;27:2081-2089.
    PubMed     Abstract available


  561. BART SM, Flaherty E, Alpert T, Carlson S, et al
    Multiple Transmission Chains within COVID-19 Cluster, Connecticut, USA, 2020(1).
    Emerg Infect Dis. 2021;27:2669-2672.
    PubMed     Abstract available


    December 2020
  562. CHOE PG, Kim KH, Kang CK, Suh HJ, et al
    Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  563. SHAKIBA M, Nazemipour M, Salari A, Mehrabian F, et al
    Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  564. JONES JM, Kracalik I, Rana MM, Nguyen A, et al
    SARS-CoV-2 Infections among Recent Organ Recipients, March-May 2020, United States.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  565. HOSODA T, Harada S, Okamoto K, Ishino S, et al
    COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  566. AMENDOLA A, Bianchi S, Gori M, Colzani D, et al
    Evidence of SARS-CoV-2 RNA in an Oropharyngeal Swab Specimen, Milan, Italy, Early December 2019.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  567. WOLFF L, Martiny D, Deyi VYM, Maillart E, et al
    COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  568. LEWIS NM, Duca LM, Marcenac P, Dietrich EA, et al
    Characteristics and Timing of Initial Virus Shedding in Severe Acute Respiratory Syndrome Coronavirus 2, Utah, USA.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  569. TRENHOLME A, Webb R, Lawrence S, Arrol S, et al
    COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  570. MULLER N, Kunze M, Steitz F, Saad NJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak Related to a Nightclub, Germany, 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  571. AKHMETZHANOV AR
    Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.
    Emerg Infect Dis. 2020;26:3106.
    PubMed    


  572. HEMIDA MG, Chu DKW, Chor YY, Cheng SMS, et al
    Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016-2018.
    Emerg Infect Dis. 2020;26:3089-3091.
    PubMed     Abstract available


  573. SUAREZ DL, Pantin-Jackwood MJ, Swayne DE, Lee SA, et al
    Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry.
    Emerg Infect Dis. 2020;26:3074-3076.
    PubMed     Abstract available


  574. MURAKAMI S, Kitamura T, Suzuki J, Sato R, et al
    Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan.
    Emerg Infect Dis. 2020;26:3025-3029.
    PubMed     Abstract available


  575. LAITON-DONATO K, Villabona-Arenas CJ, Usme-Ciro JA, Franco-Munoz C, et al
    Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia.
    Emerg Infect Dis. 2020;26:2854-2862.
    PubMed     Abstract available


  576. KUO SC, Tsou HH, Wu HY, Hsu YT, et al
    Nonpolio Enterovirus Activity during the COVID-19 Pandemic, Taiwan, 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  577. GALLAIS F, Velay A, Nazon C, Wendling MJ, et al
    Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  578. YADOULETON A, Sander AL, Moreira-Soto A, Tchibozo C, et al
    Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  579. GUERRIERO M, Bisoffi Z, Poli A, Micheletto C, et al
    Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


    November 2020
  580. LEE EJ, Kim DH, Chang SH, Suh SB, et al
    Absence of SARS-CoV-2 Transmission from Children in Isolation to Guardians, South Korea.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  581. STAINES HM, Kirwan DE, Clark DJ, Adams ER, et al
    IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  582. HOGAN CA, Gombar S, Wang H, Roltgen K, et al
    Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  583. YOON Y, Choi GJ, Kim JY, Kim KR, et al
    Childcare Exposure to Severe Acute Respiratory Syndrome Coronavirus 2 for 4-Year-Old Presymptomatic Child, South Korea.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  584. HOPEWELL PC, Reichman LB, Castro KG
    Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  585. SHIMOTSU ST, Johnson ARL, Berke EM, Griffin DO, et al
    COVID-19 Infection Control Measures in Long-Term Care Facility, Pennsylvania, USA.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  586. DUY C, Nong VM, Van Ngo A, Doan TT, et al
    Nosocomial Coronavirus Disease Outbreak Containment, Hanoi, Vietnam, March-April 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  587. HAMMER AS, Quaade ML, Rasmussen TB, Fonager J, et al
    SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  588. STONOGA ETS, de Almeida Lanzoni L, Rebutini PZ, Permegiani de Oliveira AL, et al
    Intrauterine Transmission of SARS-CoV-2.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  589. WANG H, Hogan CA, Miller JA, Sahoo MK, et al
    Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  590. PERETTI-WATEL P, Seror V, Cortaredona S, Launay O, et al
    Attitudes about COVID-19 Lockdown among General Population, France, March 2020.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  591. YAN G, Ang A, Tham SM, Ng A, et al
    Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan.
    Emerg Infect Dis. 2020;27.
    PubMed    


  592. LIM SYD, Tey HL
    Large-Scale Isolation Facilities and Potential for Secondary Infectious Disease Outbreak.
    Emerg Infect Dis. 2020;27.
    PubMed    


  593. FEEHAN AK, Velasco C, Fort D, Burton JH, et al
    Racial and Workplace Disparities in Seroprevalence of SARS-CoV-2, Baton Rouge, Louisiana, USA.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  594. DIA N, Lakh NA, Diagne MM, Mbaye KD, et al
    COVID-19 Outbreak, Senegal, 2020.
    Emerg Infect Dis. 2020;26:2772-2774.
    PubMed     Abstract available


  595. JOSEPH NT, Stanhope KK, Badell ML, Horton JP, et al
    Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA.
    Emerg Infect Dis. 2020;26:2787-2789.
    PubMed     Abstract available


    October 2020
  596. CHAN PKS, Lui G, Hachim A, Ko RLW, et al
    Serologic Responses in Healthy Adult with SARS-CoV-2 Reinfection, Hong Kong, August 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  597. FREULING CM, Breithaupt A, Muller T, Sehl J, et al
    Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  598. MARR KA, Platt A, Tornheim JA, Zhang SX, et al
    Aspergillosis Complicating Severe Coronavirus Disease.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  599. GUZZETTA G, Riccardo F, Marziano V, Poletti P, et al
    Impact of a Nationwide Lockdown on SARS-CoV-2 Transmissibility, Italy.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  600. WALTENBURG MA, Rose CE, Victoroff T, Butterfield M, et al
    Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  601. CHAU NVV, Hong NTT, Ngoc NM, Thanh TT, et al
    Superspreading Event of SARS-CoV-2 Infection at a Bar, Ho Chi Minh City, Vietnam.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  602. SCHWARZKOPF S, Krawczyk A, Knop D, Klump H, et al
    Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  603. CHOE PG, Kang CK, Suh HJ, Jung J, et al
    Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  604. CHAW L, Koh WC, Jamaludin SA, Naing L, et al
    Analysis of SARS-CoV-2 Transmission in Different Settings, Brunei.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  605. OKARSKA-NAPIERALA M, Mandziuk J, Kuchar E
    SARS-CoV-2 Cluster in Nursery, Poland.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


  606. ULRICH L, Wernike K, Hoffmann D, Mettenleiter TC, et al
    Experimental Infection of Cattle with SARS-CoV-2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  607. CHO EY, Choi EH, Kim JH
    Interpreting Transmissibility of COVID-19 in Children.
    Emerg Infect Dis. 2020;26.
    PubMed    


  608. CALCAGNO A, Ghisetti V, Emanuele T, Trunfio M, et al
    Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy.
    Emerg Infect Dis. 2020;27.
    PubMed     Abstract available


    September 2020
  609. SPEAKE H, Phillips A, Chong T, Sikazwe C, et al
    Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  610. MOSS R, Wood J, Brown D, Shearer FM, et al
    Coronavirus Disease Model to Inform Transmission Reducing Measures and Health System Preparedness, Australia.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  611. MORLEY GL, Taylor S, Jossi S, Perez-Toledo M, et al
    Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  612. AKINBAMI LJ, Vuong N, Petersen LR, Sami S, et al
    SARS-CoV-2 Seroprevalence among Healthcare, First Response, and Public Safety Personnel, Detroit Metropolitan Area, Michigan, USA, May-June 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  613. WANG X, Du Z, Huang G, Pasco RF, et al
    Effects of Cocooning on Coronavirus Disease Rates after Relaxing Social Distancing.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  614. HOMOLKA S, Paulowski L, Andres S, Hillemann D, et al
    Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  615. CHOI EM, Chu DKW, Cheng PKC, Tsang DNC, et al
    In-Flight Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  616. KHANH NC, Thai PQ, Quach HL, Thi NH, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 During Long Flight.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  617. BARRS VR, Peiris M, Tam KWS, Law PYT, et al
    SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  618. DOUNG-NGERN P, Suphanchaimat R, Panjangampatthana A, Janekrongtham C, et al
    Case-Control Study of Use of Personal Protective Measures and Risk for Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Thailand.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  619. BYRNE RL, Kay GA, Kontogianni K, Aljayyoussi G, et al
    Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  620. MIGLIORI GB, Thong PM, Akkerman O, Alffenaar JW, et al
    Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  621. LU J, Yang Z
    COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed    


  622. RULE AM
    COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed    


  623. BIGGERSTAFF M, Cowling BJ, Cucunuba ZM, Dinh L, et al
    Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  624. HE YC, Chen F
    Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    Emerg Infect Dis. 2020;26:2297-2298.
    PubMed    


    August 2020
  625. HU WT, Howell JC, Ozturk T, Benameur K, et al
    Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  626. CHOWDHARY A, Tarai B, Singh A, Sharma A, et al
    Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  627. WONG NS, Leung CC, Lee SS
    Abrupt Subsidence of Seasonal Influenza after Coronavirus Disease Outbreak, Hong Kong, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  628. KIM SY, Lee J, Sung H, Lee H, et al
    Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available



  629. Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama, Japan, February 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  630. BAE SH, Shin H, Koo HY, Lee SW, et al
    Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  631. PARK SW, Sun K, Viboud C, Grenfell BT, et al
    Potential Role of Social Distancing in Mitigating Spread of Coronavirus Disease, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  632. GARIGLIANY M, Van Laere AS, Clercx C, Giet D, et al
    SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  633. SAFDAR N, Moreno GK, Braun KM, Friedrich TC, et al
    Using Virus Sequencing to Determine Source of SARS-CoV-2 Transmission for Healthcare Worker.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  634. PERERA RAPM, Tso E, Tsang OTY, Tsang DNC, et al
    SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  635. TOTURA A, Livingston V, Frick O, Dyer D, et al
    Small Particle Aerosol Exposure of African Green Monkeys to MERS-CoV as a Model for Highly Pathogenic Coronavirus Infection.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  636. GE Y, Sun S
    Estimation of Coronavirus Disease Case-Fatality Risk in Real Time.
    Emerg Infect Dis. 2020;26:1922-1923.
    PubMed     Abstract available


    July 2020
  637. FEEHAN AK, Fort D, Garcia-Diaz J, Price-Haywood E, et al
    Seroprevalence of SARS-CoV-2 and Infection Fatality Ratio, Orleans and Jefferson Parishes, Louisiana, USA, May 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  638. LEE HH, Lin SH
    Effects of COVID-19 Prevention Measures on Other Common Infections, Taiwan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  639. OKUHAMA A, Ishikane M, Katagiri D, Kanda K, et al
    Detection of SARS-CoV-2 in Hemodialysis Effluent of Patient with COVID-19 Pneumonia, Japan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  640. LAU SKP, Wong ACP, Luk HKH, Li KSM, et al
    Differential Tropism of SARS-CoV and SARS-CoV-2 in Bat Cells.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  641. PETERSEN MS, Strom M, Christiansen DH, Fjallsbak JP, et al
    Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  642. KIM T
    Work Environment Surrounding COVID-19 Outbreak in Call Center, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed    


  643. SUNG H, Han MG, Yoo CK, Lee SW, et al
    Nationwide External Quality Assessment of SARS-CoV-2 Molecular Testing, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  644. DAS MK, Chaudhary A, Bryan A, Wener MH, et al
    Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  645. WANG X, Pasco RF, Du Z, Petty M, et al
    Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand, Central Texas, USA.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  646. PARK YJ, Choe YJ, Park O, Park SY, et al
    Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  647. KWAK N, Hwang SS, Yim JJ
    Effect of COVID-19 on Tuberculosis Notification, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  648. THAM SM, Lim WY, Lee CK, Loh J, et al
    Four Patients with COVID-19 and Tuberculosis, Singapore, April-May 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  649. YAO Z, Chen J, Wang Q, Liu W, et al
    Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  650. CHUGHTAI AA, Seale H, Macintyre CR
    Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  651. PANEPINTO JA, Brandow A, Mucalo L, Yusuf F, et al
    Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  652. KANG CR, Lee JY, Park Y, Huh IS, et al
    Coronavirus Disease Exposure and Spread from Nightclubs, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  653. VIVANTI AJ, Mattern J, Vauloup-Fellous C, Jani J, et al
    Retrospective Description of Pregnant Women Infected with Severe Acute Respiratory Syndrome Coronavirus 2, France.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  654. LAKKASANI S, Chan KH, Shaaban HS
    Clostridiodes difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed    


  655. HALLOWELL BD, Carlson CM, Jacobs JR, Pomeroy M, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure Among Evacuees from Wuhan, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  656. ADAMS ML, Katz DL, Grandpre J
    Updated Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  657. GAO J, Li W, Hu X, Wei Y, et al
    Disappearance of SARS-CoV-2 Antibodies in Infants Born to Women with COVID-19, Wuhan, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  658. LESHEM E, Afek A, Kreiss Y
    Buying Time with COVID-19 Outbreak Response, Israel.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  659. HOGAN CA, Garamani N, Sahoo MK, Huang C, et al
    Retrospective Screening for SARS-CoV-2 RNA in California, USA, Late 2019.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  660. MIU A, Cao H, Zhang B, Zhang H, et al
    Review of Mental Health Response to COVID-19, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  661. FEASTER M, Goh YY
    High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  662. BUGEMBE DL, Kayiwa J, Phan MVT, Tushabe P, et al
    Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  663. CHAN KH, Slim J, Shaaban HS
    Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
    Emerg Infect Dis. 2020;26.
    PubMed    


  664. CHAN KH, Slim J
    Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    Emerg Infect Dis. 2020;26.
    PubMed    


  665. WANG L, Maddox C, Terio K, Lanka S, et al
    Detection and Characterization of New Coronavirus in Bottlenose Dolphin, United States, 2019.
    Emerg Infect Dis. 2020;26:1610-1612.
    PubMed     Abstract available


  666. PADEN CR, Tao Y, Queen K, Zhang J, et al
    Rapid, Sensitive, Full-Genome Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  667. IKEUCHI K, Saito M, Yamamoto S, Nagai H, et al
    Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  668. BENEZIT F, Le Bot A, Jouneau S, Lemaitre F, et al
    COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  669. LAU SKP, Luk HKH, Wong ACP, Li KSM, et al
    Possible Bat Origin of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26:1542-1547.
    PubMed     Abstract available


  670. KRATZEL A, Todt D, V'kovski P, Steiner S, et al
    Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols.
    Emerg Infect Dis. 2020;26:1592-1595.
    PubMed     Abstract available


  671. ALZAHRANI A, Kujawski SA, Abedi GR, Tunkar S, et al
    Surveillance and Testing for Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, March 2016-March 2019.
    Emerg Infect Dis. 2020;26:1571-1574.
    PubMed     Abstract available


    June 2020
  672. LIU J, Huang J, Xiang D
    Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.
    Emerg Infect Dis. 2020;29.
    PubMed     Abstract available


  673. L'HUILLIER AG, Torriani G, Pigny F, Kaiser L, et al
    Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  674. BROWN NE, Bryant-Genevier J, Bandy U, Browning CA, et al
    Antibody Responses after Classroom Exposure to Teacher with Coronavirus Disease, March 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  675. CHOE PG, Kang CK, Suh HJ, Jung J, et al
    Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  676. PALMER K, Dick J, French W, Floro L, et al
    Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  677. MOSES FW, Gonzalez-Rothi R, Schmidt G
    COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed    


  678. PASTORINO B, Touret F, Gilles M, de Lamballerie X, et al
    Prolonged Infectivity of SARS-CoV-2 in Fomites.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  679. BORRAS-BERMEJO B, Martinez-Gomez X, San Miguel MG, Esperalba J, et al
    Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  680. KANG E, Lee SY, Jung H, Kim MS, et al
    Operating Protocols of a Community Treatment Center for Isolation of Patients with Coronavirus Disease, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  681. CHOI WS, Kim HS, Kim B, Nam S, et al
    Community Treatment Centers for Isolation of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  682. LEE YH, Hong CM, Kim DH, Lee TH, et al
    Clinical Course of Asymptomatic and Mildly Symptomatic Patients with Coronavirus Disease Admitted to Community Treatment Centers, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  683. FEARS AC, Klimstra WB, Duprex P, Hartman A, et al
    Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  684. BANERJEE A, Nasir JA, Budylowski P, Yip L, et al
    Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  685. LI Y, Zhao R, Zheng S, Chen X, et al
    Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  686. LIU J, Liao X, Qian S, Yuan J, et al
    Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  687. ARASHIRO T, Furukawa K, Nakamura A
    COVID-19 in 2 Persons with Mild Upper Respiratory Symptoms on a Cruise Ship, Japan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  688. TANG A, Tong ZD, Wang HL, Dai YX, et al
    Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  689. HAN X, Wei X, Alwalid O, Cao Y, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 among Asymptomatic Workers Screened for Work Resumption, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  690. CLAPHAM H, Hay J, Routledge I, Takahashi S, et al
    Seroepidemiologic Study Designs for Determining SARS-COV-2 Transmission and Immunity.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  691. FURUSE Y, Sando E, Tsuchiya N, Miyahara R, et al
    Clusters of Coronavirus Disease in Communities, Japan, January-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  692. DU Z, Xu X, Wang L, Fox SJ, et al
    Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  693. MATSON MJ, Yinda CK, Seifert SN, Bushmaker T, et al
    Effect of Environmental Conditions on SARS-CoV-2 Stability in Human Nasal Mucus and Sputum.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  694. HAN MS, Seong MW, Kim N, Shin S, et al
    Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19, Seoul.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  695. LECHIEN JR, Chetrit A, Chekkoury-Idrissi Y, Distinguin L, et al
    Parotitis-Like Symptoms Associated with COVID-19, France, March-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  696. FISCHER RJ, Morris DH, van Doremalen N, Sarchette S, et al
    Effectiveness of N95 Respirator Decontamination and Reuse against SARS-CoV-2 Virus.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  697. LUI G, Lai CKC, Chen Z, Tong SLY, et al
    SARS-CoV-2 RNA Detection on Disposable Wooden Chopsticks, Hong Kong.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  698. PANNU J
    Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures.
    Emerg Infect Dis. 2020;26.
    PubMed    


  699. RYU S, Ali ST, Jang C, Kim B, et al
    Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  700. BENAMEUR K, Agarwal A, Auld SC, Butters MP, et al
    Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  701. KAIN T, Lindsay PJ, Adhikari NKJ, Arabi YM, et al
    Pharmacologic Treatments and Supportive Care for Middle East Respiratory Syndrome.
    Emerg Infect Dis. 2020;26:1102-1112.
    PubMed     Abstract available


    May 2020
  702. CHU VT, Freeman-Ponder B, Lindquist S, Spitters C, et al
    Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  703. BARTOLINI B, Rueca M, Gruber CEM, Messina F, et al
    SARS-CoV-2 Phylogenetic Analysis, Lazio Region, Italy, February-March 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  704. SUCHOMEL M, Eggers M, Maier S, Kramer A, et al
    Evaluation of World Health Organization-Recommended Hand Hygiene Formulations.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  705. ZHANG W, Cheng W, Luo L, Ma Y, et al
    Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  706. ZAYET S, Klopfenstein T, Kovacs R, Stancescu S, et al
    Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  707. SANDHU A, Tillotson G, Polistico J, Salimnia H, et al
    Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  708. MARTINES RB, Ritter JM, Matkovic E, Gary J, et al
    Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  709. YUSEF D, Hayajneh W, Awad S, Momany S, et al
    Large Outbreak of Coronavirus Disease among Wedding Attendees, Jordan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  710. MOGLING R, Meijer A, Berginc N, Bruisten S, et al
    Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  711. JIANG FC, Jiang XL, Wang ZG, Meng ZH, et al
    Detection of Severe Acute Respiratory Syndrome Coronavirus 2 RNA on Surfaces in Quarantine Rooms.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  712. XIAO F, Sun J, Xu Y, Li F, et al
    Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  713. DU Z, Wang L, Cauchemez S, Xu X, et al
    Risk for Transportation of 2019 Novel Coronavirus Disease from Wuhan to Other Cities in China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  714. TONG ZD, Tang A, Li KF, Li P, et al
    Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  715. ADACHI T, Chong JM, Nakajima N, Sano M, et al
    Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  716. JANG S, Han SH, Rhee JY
    Cluster of Coronavirus Disease Associated with Fitness Dance Classes, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  717. FERGUSON J, Rosser JI, Quintero O, Scott J, et al
    Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  718. KHODAMORADI Z, Boogar SS, Shirazi FKH, Kouhi P, et al
    COVID-19 and Acute Pulmonary Embolism in Postpartum Patient.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  719. LU X, Wang L, Sakthivel SK, Whitaker B, et al
    US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  720. BESUTTI G, Bonacini R, Iotti V, Marini G, et al
    Abdominal Visceral Infarction in 3 Patients with COVID-19.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  721. HIJNEN D, Marzano AV, Eyerich K, GeurtsvanKessel C, et al
    SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  722. HUANG G, Kovalic AJ, Graber CJ
    Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  723. SUN J, Xiao J, Sun R, Tang X, et al
    Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  724. FURUKAWA NW, Brooks JT, Sobel J
    Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  725. OKBA NMA, Widjaja I, Li W, GeurtsvanKessel CH, et al
    Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies.
    Emerg Infect Dis. 2020;26:1024-1027.
    PubMed     Abstract available


    April 2020
  726. GRIFFIN DO, Jensen A, Khan M, Chin J, et al
    Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  727. BLAIZE M, Mayaux J, Nabet C, Lampros A, et al
    Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  728. MATRAJT L, Leung T
    Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  729. SOO RJJ, Chiew CJ, Ma S, Pung R, et al
    Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  730. KUO SC, Shih SM, Chien LH, Hsiung CA, et al
    Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  731. MUNIZ-RODRIGUEZ K, Chowell G, Cheung CH, Jia D, et al
    Doubling Time of the COVID-19 Epidemic by Province, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  732. LUO Y, Trevathan E, Qian Z, Li Y, et al
    Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  733. CHIANG CH, Chiang CH, Chiang CH, Chen YC, et al
    The Practice of Wearing Surgical Masks during the COVID-19 Pandemic.
    Emerg Infect Dis. 2020;26.
    PubMed    


  734. PARK SY, Kim YM, Yi S, Lee S, et al
    Coronavirus Disease Outbreak in Call Center, South Korea.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  735. ADAMS ML, Katz DL, Grandpre J
    Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  736. MUNIZ-RODRIGUEZ K, Fung IC, Ferdosi SR, Ofori SK, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Potential, Iran, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  737. DUPLOYEZ C, Le Guern R, Tinez C, Lejeune AL, et al
    Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  738. KWOK KO, Li KK, Chan HHH, Yi YY, et al
    Community Responses during Early Phase of COVID-19 Epidemic, Hong Kong.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  739. WAGGONER JJ, Stittleburg V, Pond R, Saklawi Y, et al
    Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  740. ARIMA Y, Shimada T, Suzuki M, Suzuki T, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  741. GUO ZD, Wang ZY, Zhang SF, Li X, et al
    Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  742. PONGPIRUL WA, Mott JA, Woodring JV, Uyeki TM, et al
    Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  743. OKBA NMA, Muller MA, Li W, Wang C, et al
    Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  744. SANCHE S, Lin YT, Xu C, Romero-Severson E, et al
    High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  745. CHANG L, Zhao L, Gong H, Wang L, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  746. LE TQM, Takemura T, Moi ML, Nabeshima T, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  747. LU J, Gu J, Li K, Xu C, et al
    COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


    March 2020
  748. LI C, Ji F, Wang L, Wang L, et al
    Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  749. LIN C, Braund WE, Auerbach J, Chou JH, et al
    Policy Decisions and Use of Information Technology to Fight 2019 Novel Coronavirus Disease, Taiwan.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  750. DE SALAZAR PM, Niehus R, Taylor A, Buckee CO, et al
    Identifying Locations with Possible Undetected Imported Severe Acute Respiratory Syndrome Coronavirus 2 Cases by Using Importation Predictions.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  751. DONG L, Bouey J
    Public Mental Health Crisis during COVID-19 Pandemic, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  752. JIN M, Tong Q
    Rhabdomyolysis as Potential Late Complication Associated with COVID-19.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  753. OLSEN SJ, Chen MY, Liu YL, Witschi M, et al
    Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  754. DU Z, Xu X, Wu Y, Wang L, et al
    Serial Interval of COVID-19 among Publicly Reported Confirmed Cases.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  755. FRIEDEN TR, Lee CT
    Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  756. FAN J, Liu X, Pan W, Douglas MW, et al
    Epidemiology of 2019 Novel Coronavirus Disease-19 in Gansu Province, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  757. MIZUMOTO K, Chowell G
    Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  758. WILSON N, Kvalsvig A, Barnard LT, Baker MG, et al
    Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  759. CAI J, Sun W, Huang J, Gamber M, et al
    Indirect Virus Transmission in Cluster of COVID-19 Cases, Wenzhou, China, 2020.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  760. HARCOURT J, Tamin A, Lu X, Kamili S, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with 2019 Novel Coronavirus Disease, United States.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


  761. WU X, Cai Y, Huang X, Yu X, et al
    Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China.
    Emerg Infect Dis. 2020;26.
    PubMed     Abstract available


    February 2020
  762. KILLERBY ME, Biggs HM, Midgley CM, Gerber SI, et al
    Middle East Respiratory Syndrome Coronavirus Transmission.
    Emerg Infect Dis. 2020;26:191-198.
    PubMed     Abstract available


  763. BOLEY PA, Alhamo MA, Lossie G, Yadav KK, et al
    Porcine Deltacoronavirus Infection and Transmission in Poultry, United States(1).
    Emerg Infect Dis. 2020;26:255-265.
    PubMed     Abstract available


    January 2020
  764. ALANAZI KH, Abedi GR, Midgley CM, Alkhamis A, et al
    Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia.
    Emerg Infect Dis. 2020;26:166-168.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.